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ABSTRACT 
 
The objectives of this study are twofold: firstly, to give an account of the 
current methods of knowledge production, and secondly to contribute a 
consultation piece on oncologists’ perceptions of non-technical issues regarding 
the ethical, legal and social implications of microfluidic lab-on-chip technology 
(MF LOC). Two connected theses statements are put forth. First, understanding 
the transformations of knowledge production will allow for a more socially and 
ethically informed mode of governance to emerge. Second, it is important to 
consider who might use the technology and how it might impact institutions and 
individuals.  
 
Interviews were conducted with 31 Canadian oncologists during August 
2004 to February 2005. Qualitative analysis was used to examine the oncologists’ 
responses. It was found that of the different types of knowledge production that 
were reviewed (Mode-1, Mode-2, Triple Helix, and Post-normal science) the 
Triple Helix thesis was most supported. However, an integration of characteristics 
of Mode-2 with the Triple Helix thesis best accounts for the current description of 
knowledge production. The principles inherent in Post-Normal Science provide a 
starting point for developing an approach for building capacity for an independent 
institution that examines the ethical, legal and social concerns regarding 
transformative technologies. In relation to the second thesis, the results indicate 
that MF LOC devices have great potential to transform institutional practices and 
affect individual lives. And it is important to understand that the oncologists 
studied constructed their understanding of MF LOC technology within a scientific 
and biomedical repertoire consequently, future research should assess the 
perceptions and concerns of other groups of people that are different from the 
scientific and biomedical repertoire.  
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1.0 CHAPTER ONE 
1.1 PROLOGUE             
 Time: 790, 000 BCE the dark night sky is cascaded with stars and a nearly 
perfect round moon, the air has a crisp bite and it will not be long before the cold season 
arrives. Beasley (an early hominid) sits shivering in his makeshift hut of twigs and 
branches from an olive tree. Images start flashing across Beasley’s mind…memories of a 
time not too long ago of when he ran away from a brilliant beam of light that seemed to 
dance across the trees, a light that gave off an immense sensation of warmth. A thought 
occurs to Beasley that perhaps there was something in the wood of the trees that made the 
warmth come out. He grabs a couple sticks of wood from off the ground and starts 
tapping them on a rock, he does this for a while but nothing happens. He doesn’t give up; 
he starts rubbing the sticks together between his hands and immediately feels warmer 
from the friction. He sits rubbing the sticks for a long time until finally a small billow of 
smoke emerges followed by a young flickering flame. He has created ‘fire’. Content, 
Beasley curls up and falls asleep by his small flame of warmth. A little while later he 
wakes up to find his entire hut engulfed in flames. Feeling both fascinated and distraught 
he watches as the last bit of his hut turns to ash. He immediately begins rebuilding his 
home and the next night he digs a hole in the ground big enough to contain the fire…an 
innovation known as the ‘fire pit’. 
 In a sense we (humanity) are still like Beasley, observing what is in our 
environment, responding with certain actions and witnessing the effects. The need 
to control and manipulate our surroundings through technological innovation has 
become as inherent to human nature as flying is to an eagle. Our history with 
technology has taken us down paths of both wondrous discovery and enormous 
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devastation1. The creation of materials, weapons, medicine, automobiles, 
plumbing, energy sources, computers, better housing, etc. has enhanced our way 
of living and protected us from outside elements, but the path of technology is a 
two-way street that has also led to pollution, industrial disasters (e.g., Chernobyl), 
divisions of social class, and more devastating war tactics (Leiss, 2001). In order 
to anticipate the impacts and reduce risks it is thus becoming more important in 
society to understand how we generate knowledge of the world around us, and 
how that knowledge then is managed and transferred into technological 
applications. This first chapter will reveal the central thesis statements and 
corresponding questions along with the purpose and significance of the study. A 
brief discussion of the definition of microfluidic lab-on-chip (MF LOC) device is 
also provided.  
 
 1.2 STATEMENT OF THESIS, QUESTIONS AND PURPOSE 
Most individuals are born into the world with the ability to see, touch, 
smell, taste and feel. But what happens when our senses do not provide us with 
enough information to probe the world around us, or even the processes within 
us?  Humans develop tools such as telescopes that enable one to peer into other 
galaxies, or microscopes to observe microscopic phenomenon. Scientists and 
engineers are currently working on a portable microfluidic lab-on-chip device 
capable of analyzing an individual’s deoxyribonucleic acid (DNA) with the 
 
1 Technology (definition): “Application of knowledge to the practical aims of human life or to 
changing and manipulating the human environment” (Encylopedia Britanica, 2005). 
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intention to monitor changes within cancer cells (Pilarski et al., 2004). The 
social concerns arising from the possible applications of this technology focus on 
issues of patient confidentiality and the privacy of genetic information including 
inappropriate use of genetic information to facilitate genetic discrimination.  
Since this technology (MF LOC device) is still in the developmental phase, it is 
important that analysis of various actors who will potentially be affected by the 
use of this technology be conducted. This research examines how Canadian 
oncologists view how this device may impact not only their patient’s lives but 
also their own practice. My main argument is that by gaining insight into the 
underlying mechanisms of how a society adopts certain technologies will allow 
for greater understanding of the ethical, legal and social implications of emerging 
technologies.   
Advances in biotechnology and genetic testing have transformed the way 
health and illness are perceived, researched, diagnosed, and treated (Conrad, 
1992). In an era dubbed the ‘information age,’ the accumulation of ‘new 
knowledge’ is given greater weight as a driver of economic, environmental, and 
societal sustainability. But how and where that knowledge is created are at the 
center of mass debates between ideologies of scientific certainty and the social 
construction of knowledge (Nowotny, et al. 2001; Gibbons, 1999 and De Marchi 
& Ravetz 1999).  
The development of a transformative technology has to overcome barriers 
both tangible and abstract. The tangible barriers include cost and production, 
whereas the abstract barriers include social acceptance and regulations. My work 
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focuses mainly on the social barriers, and I use qualitative analysis to understand 
the perceptions of Canadian oncologists regarding genetic testing and something 
often called “lab-on-chip” technology.  
This is a unique time to carry out research with this particular nanomedical 
technology as it is in the embryonic stage of development, and thus an 
opportunity exists to tap into the initial thoughts and reactions of what oncologists 
think about this technology and the impacts it may have on society. Two thesis 
statements are put forward. The first thesis is that understanding the 
transformations of new scientific knowledge production will allow for a more 
socially and ethically informed mode of governance to emerge. The question that 
emerges within this thesis focuses on the type of knowledge production we are 
currently experiencing. In order to respond to this issue a literature review 
combined with an analysis of the oncologists’ interview responses is provided.  
The second thesis states that it is important to consider who might use the 
technology and how that might impact certain groups of individuals. Two 
questions emerged regarding this thesis. The first is what insight might 
oncologists provide in guiding policy concerning the use of MF LOC devices at 
both the institutional and individual level? The second question is how does a 
scientific and biomedical repertoire shape the oncologists’ concerns regarding the 
acceptance and application of MF LOC Devices? The response to these questions 
will emerge primarily through a qualitative analysis of the oncologists 
interviewed, combined with input from various authors compilations of subject 
matter in the area of biomedicalization. This shall contribute to a holistic 
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understanding of the social, ethical and legal concerns regarding the 
development and application of MF LOC devices.     
 
1.3 CONCEPTUALIZATION OF MICROFLUIDIC LAB-ON-CHIP 
The MF LOC device is a technology that is currently under development 
in Canada (and elsewhere) by a range of oncologists, engineers and other 
researchers. It is a technology capable of carrying out a complete analysis from 
cell selection, to employing polymerase chain reaction (PCR) techniques, and 
capillary electrophoresis within a relatively short period of time (e.g., 20 
minutes). Essentially, the device can be used to decode DNA and to help indicate 
the presence of certain genes, and to help tailor individual drug prescriptions.  
Backhouse et al. (2003: 377) describes the intended process and use of the MF 
LOC device: 
Microfluidic technology applies photolithographic methods, glass etching 
and bonding to produce microchannels in glass that have dimensions 
similar to the capillaries often used in molecular biology. The 
development of miniaturized devices capable of automated real time 
analysis of genetic profiles is likely to enable routine genetic analysis of 
diseases such as cancer, whether for diagnosis or monitoring treatment 
throughout the course of the disease.   
 
The development of microfluidic platforms for the use in lab-on-chip 
devices has the potential to reveal detailed health information through automated 
real-time analysis (Backhouse et al., 2003). Just as large computers have been 
decreased to the size of dime-sized chips, so too have the tools of biotechnology 
undergone drastic miniaturization (Staeder, 2002). The development of 
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microfluidic lab-on-chip devices allows the time-intense laboratory tests to be 
done on automated real-time miniature lab-on-chips (Staeder, 2002). 
The major difference in the MF LOC device from existing genetic analysis 
technology is that the size of the components is drastically smaller and can fit into 
the palm of one’s hand. The advantages of MF LOC devices include decreased 
time and increased sensitivity of diagnosis, targeted and tailored treatment and 
decreased cost of laboratory supplies (e.g., reagents): "The potential ability of 
automated chip platforms to carry out many of the tasks normally performed by 
technologists and/or multiple large and expensive pieces of equipment is 
enormous" (Pilarski et al., 2004: 41). Microfluidic systems that employ nanoscale 
molecular manipulations will enhance disease classification and help direct proper 
disease management practices for patients. Since horrendous side effects occur in 
a small percentage of patients on certain prescription and non-prescription drugs, 
MF LOC devices could be used to offer individually tailored health care. The 
ability to effectively pre-screen and monitor patients would be cost effective and 
help identify high-risk genetic profiles. By making medical interventions more 
targeted, efficient and faster, health care costs are decreased and value is added to 
the economy (Pilarski et al., 2004).    
 
1.4 SIGNIFICANCE OF THE STUDY 
The introduction of transformative technologies into society inevitably 
produces winners and losers. An extensive examination of the ethical, legal and 
social implications of such technologies will contribute to a more “socially 
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sensitive” and better-informed decision making capacity. This study is 
significant in that it attempts to examine some of players (oncologists) involved in 
developing knowledge and technology, as well; this study examines the ethical, 
social and legal issues that need to be addressed before commercializing MF LOC 
devices.  
Currently, there are only a few genetic diseases that can be tested for 
including Huntingtons Chorea, Cystic Fibrosis and Haemochromatosis. Since 
many diseases are polygenic, and as such have multiple gene components, 
deriving the genetic heritage of the disease is not an easy task (Pilarski et al., 
2004).  If an individual is found to be genetically predisposed to 
Haemochromatosis, a condition that may end in organ failure and death; one can 
dramatically reduce the development of the disease by adjusting to healthy 
lifestyle changes (Pilarski et al., 2004). Clearly, there are significant advantages to 
the development of MF LOC devices; however, it will come with great social 
responsibility and require elaborate cooperation between policy-makers, natural 
and social scientists, industry, government, and the general public to ensure the 
appropriate application with minimal risk to individuals or society. 
The increased capacity of databases to store vast amounts of information 
have created a situation whereby sensitive patient health information is now being 
stored electronically. The implications of archiving genetic test results on an 
electronic database are tremendous. Questions of who has access to this 
information emerge at the forefront. If patient confidentiality cannot be ensured, 
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then patient willingness to partake in the benefits of genetic testing may be 
limited. 
In an age in which medical information is being collected in databases that 
are increasingly accessible to any health care provider, this will present a 
dangerous situation in which very sensitive information is widely 
available while being very valuable to insurance companies and others. 
Large databases of personal information are likely to be accumulated in 
the future (Pilarski et al., 2004: 41).  
 
There are currently no laws in Canada prohibiting companies or insurance 
agencies from requesting a genetic profile of employees or clients.  The potential 
for genetic discrimination exists and the time to shape policy to ensure social 
justice is now. This is particularly so given that the development and use of 
portable, rapid, low-cost, easy-to-use MF LOC devices for genetic analysis 
creates the potential for a wide-range of non-clinical uses by insurance 
companies, employers, and even by individual consumers (Pilarski et al, 2004). 
The likely chance that MF LOC devices will be used for other purposes requires 
an extensive expert and public consultation process in order to educate and then 
consult with end users like the medical community, government regulators, and 
the general public to determine societal priorities and the appropriate level of risk 
(Pilarski et al., 2004). 
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2.0 CHAPTER TWO: OBSERVATIONS OF THE 
KNOWLEDGE PRODUCTION PROCESS 
 
 
The purpose of this chapter is to lay out the characterization of the various 
types of knowledge production models that are used in this thesis such as Mode-1, 
Mode-2, Triple Helix and Post-Normal Science. The convergence of fields such 
as biotechnology, nanotechnology and information technology are creating new 
forms of knowledge and novel applications of technology. Knowledge-based 
economies are characterized by increased interest in applied versus pure research 
with the resulting transformation to the nature and organization of scientific 
knowledge production and application. Developing and applying new scientific 
knowledge in the form of new technologies is a primary source of economic 
growth in knowledge-based economies. It is also the source of many uncertainties 
and unintended consequences.  
The microfluidic lab-on-chip is one such technology currently being 
developed in Canada through a national collaboration of researchers, scientists 
and oncologists. This technology, in the form of a handheld, automated device, is 
intended to enable doctors to monitor, diagnose and provide individualized care to 
patients through the analysis of single cell material, including specific genes. This 
analytical work will be possible more quickly and without the need for extensive 
laboratory space and equipment as is currently the case.  
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Given that the current regulatory and legal frameworks remain 
unchanged, it is possible that the MF LOC device may become institutionalized 
into corporations and used for the selection of genetically superior employees. 
Insurance agencies, if allowed, are also likely to use the device to assess their 
client’s genetic profile and to set differential premiums for individuals who are 
found to be ‘predisposed’ to certain genetic ailments. A society that identifies 
humans according to their genetic code would inevitably witness a new form of 
discrimination based on genetics. It is especially important to examine the 
knowledge production and networks involved behind developing the tools that are 
used to access and assess genetic information.  
Current models of knowledge production are debated by sociologists such 
as Gibbons et al. (1994) regarding the concepts of Mode-1 and Mode-2 models of 
knowledge production and Etzkowitz and Leydesdorff (2000) regarding the Triple 
Helix model of knowledge production. Additionally, Post-Normal Science is 
emerging as a concept that attempts to include extended peer communities into 
the production and guidance of novel technologies, and in science in general. This 
section addresses different theories of knowledge production using MF LOC 
devices as an illustration of an emerging technology. It is imperative to 
understand the dynamics of the new modes of knowledge production in order to 
assemble an effective, socially responsible form of governance2 which addresses  
2   The term ‘governance’ refers to the process of policy making, macro-level decision making and 
implementing regulations. Governance operates on multiple levels and includes different agents 
responsible for specific kinds of decisions (Refer to Kezar and Eckel (2004) for extended 
definition).   
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the ethical, legal and social implications of emerging technologies such as MF 
LOC devices. 
 
2.1  MODE-1 AND MODE-2 MODEL OF KNOWLEDGE PRODUCTION 
 The emergence of an open system of knowledge production is what 
Nowotny, Scott and Gibbons (2001) describe as Mode-2 science. The increasing 
complexity and uncertainty in society is reflective of a Mode-2 society (Nowotny, 
Scott and Gibbons, 2001). The differentiation between science and society is 
decreasing and a co-evolution has emerged whereby science and society both 
contribute to each other’s development (Nowotny, Scott and Gibbons, 2001). The 
co-evolution of science and society allows for a dialectical relationship in that 
science not only speaks to society but also listens to the concerns of society. The 
notion of contextualization refers to “reverse communication” where a society is 
able to impact science. Also the individuals in the process of knowledge 
production are from different arenas, from target groups in markets to legal 
regulators (Nowotny, Scott and Gibbons, 2001). The process of contextualization 
is what guides science from reliable knowledge into a more socially robust 
knowledge production system or approach (Nowotny, Scott and Gibbons, 2001).  
The institutionalization of Mode-2 knowledge production creates a new 
social contract between science and society (Gibbons, 1999). The pre-existing 
contract consists of bureaucratic-directed science leaving avenues of public  
participation up to representative institutions. The new contract would include a  
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more “socially robust” form of science that is both transparent and participative 
within society. Gibbons (1999) argues that a shift is occurring between “reliable” 
knowledge to “socially robust” knowledge. The conditions and procedures that 
have been at the foundation of science as ‘reliable knowledge’ are not changed by 
the shift to socially robust knowledge. Also “reliable knowledge” was 
incorporated and validated within boundary limitations, and as such science was 
viewed as incomplete. Knowledge was gained primarily through a consensual 
acceptance through peer groups. A socially robust knowledge regime invites the 
entire scientific community, including the public, to participate in the discourse. 
This allows new knowledge to be contested and not safeguarded within the 
environment of scientific peers. Socially robust practices allow for a more 
insightful understanding of societal impacts of emerging scientific knowledge and 
its possible applications.    
Reciprocity is important in that the public is informed of scientific 
progress while the science community understands the needs of the public 
(Gibbons, 1999). Gibbons uses the term “agora” to refer to the public space as a 
new arena of scientific discourse whereby the public can “speak back” to science.  
The agora is where the renegotiation of scientific knowledge plays out. The media 
plays an especially important role in this arena as it acts as the medium through 
which knowledge is both transferred to the public and debated by the public 
Nowotny, Scott and Gibbons,  (2001) claim that as science moves out into 
the agora, the role of scientific and technical expertise changes as expertise 
becomes more socially distributed. This pattern disrupts traditional linkages of 
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expertise and institutions. In order to combat the fragmented voice of scientific 
expertise the emergence of narratives of expertise culminates to provide a 
collective voice to scientific knowledge and applications.  
Nowotny, Scott and Gibbons (2001) characterize narratives of expertise as 
transgressive in the sense that experts have to address non-scientific issues and 
communicate those issues to a wide range of audiences. Narratives of expertise 
are collective such that not only one type of expertise can suffice in explaining the 
complexity of a phenomenon within scientific and social circumstances. 
Narratives are also self-authorizing since the heterogeneity of disciplines creates a 
built-in safeguard against dominating views from one expert domain. The links 
that reinforce the socially distributed knowledge allows for checks and balances 
within and between experts. 
In order to achieve a new social contract an element of reflexivity is 
needed to think critically of the unintentional or misappropriate applications of a 
new technology. A more open and reflexive scientific community will result in a 
socially robust knowledge production process.  The malleability of this new social 
contract allows for a renegotiation of scientific knowledge rather than a fixed 
process.  Gibbons (1999) also encourages scientists to leave the “ivory tower” to 
immerse themselves within the agora to increase the effectiveness of the social 
contract and to enhance the socially robust nature of scientific knowledge.  
In earlier writing, Gibbons et al. (1994) differentiate between Mode-1 and 
Mode-2 forms of knowledge production in order to understand the shifts of 
knowledge production. Mode-1 is characterized by a separation of knowledge 
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production and application (Gibbons et al., 1994). Consequently, the site of 
knowledge production differs from the site of its application. In Mode-1 there is a 
strong division between university and society, and in Mode-2 the university is 
characterized as weakening and being replaced by other institutions that take over 
the production of knowledge (e.g., think tanks and government or industrial 
laboratories).   
A combination exists of knowledge production and application that 
emerges from Mode-2. A shift in focus away from basic and towards applied 
research is a hallmark of Mode-2 and it gives way to a transdisciplinary approach 
to research. As explained by Nicolescu (2002) the term “transdisciplinary” refers 
to a study between, across and beyond all disciplines3. Nicolescu describes 
disciplinary research as a focus on one level of reality, whereas transdisciplinarity 
examines various levels of reality simultaneously. The term multidisciplinary 
refers to the study of a particular research topic in more than one discipline 
simultaneously; for example the Virtual College of Biotechnology at the 
University of Saskatchewan was created to study biotechnology across various 
disciplines such as commerce and economics, natural science, social science, and 
humanities. Interdisciplinary research entails the use of one discipline’s method in 
another discipline (Nicolescu, 2002). Trandiscisplinary research is guided by a 
quest for universalism and shares a mutual complementary relationship rather 
 
3 Basarab Nicolescu (2002) wrote this paper for the International Center for Transdisciplinary 
Research (CIRET).  It is a “non-profit organization, located in Paris and founded in 1987. The aim 
of our organization is to develop research in a new scientific and cultural approach - the 
transdisciplinarity - whose aim is to lay bare the nature and characteristics of the flow of 
information circulating between the various branches of knowledge”  Website found at: 
http://nicol.club.fr/ciret/english/indexen.htm  
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than an antagonistic relationship with multidisciplinary, interdisciplinary and 
disciplinary research (Nicolescu, 2002). 
In Mode-1, the ethical and social issues would be addressed primarily 
through academic means, whereas in Mode-2 the ethical and social considerations 
would include input across disciplines and organizations, again reflective of 
transdisciplinary orientations. The development of MF LOC devices is an 
example of the Mode-2 transition of knowledge production since it requires 
transdisciplinary collaboration. However, the Mode-2 model is weak in it’s 
argument that the role of the university is lessening. Since the production of the 
MF LOC device is in large part being developed by various professionals mostly 
from academic backgrounds, the Triple Helix model (Etzkowitz and Leydesdorff, 
2000), does a better job accounting for the role of the university as integral to the 
knowledge production process.  
 
2.2  TRIPLE HELIX MODEL OF KNOWLEDGE PRODUCTION 
Etzkowitz and Leydesdorff (2000) remark that Gibbons et al.’s position on 
the emergence of the new mode of production of scientific knowledge does not 
fully address linkages in the networks between industry, government and 
academia. Etzkowitz and Leydesdorff (2000) feel that the new mode of 
production (Mode-2) should be characterized as an emerging system rather than 
an outcome. Etzkowitz and Leydesdorff (2000) further argue that Mode-2 is not a 
new concept, and question why Mode-1 has emerged before Mode-2.  
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Etzkowitz and Leydesdorff (2000) refer to the Triple Helix model as a 
set of relations between university, industry and government. Negotiations 
brought on by technological change, such as information technology, between 
these institutions create a dynamic that leads to a renegotiation of underlying 
processes. The Triple Helix thesis emphasizes the university’s enhanced role in 
innovation especially in more knowledge-based societies. For example, in Canada 
the quest to develop a MF LOC device is largely driven by academic actors.  
The Triple Helix model explains the transformation of relations and 
blending of roles between university, industry and government. It is the elaborate 
and interdependent network between these organizations that fuels the drive 
behind the emergence of scientific knowledge-based innovative advances 
(Leydesdorff and Etzkowitz, 2001). Universities’ role in this matrix transforms 
from the once education-based institution to the establishment of facilitates that 
create new technological developments and new firms and spin-off companies. 
The entrepreneurial university emerges to establish economic development as 
well as academic research within its mandate (Leydesdorff and Etzkowitz, 2001). 
Universities serve as an incubator along with the cooperation between other 
university, government, and financial institutions. Technology licensing offices 
play a large part in facilitating relations between universities and companies 
(Leydesdorff and Etzkowtiz, 2001). 
The Triple Helix thesis is viewed by Etzkowitz and Leydesdorff (2000) as 
an alternative to the national systems of innovation approach that views industry 
as the leader in innovation where the state is the leading source of innovation. 
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Etzkowitz and Leydesdorff (2000) focus on communication networks as the 
driver of institutional change between university, industry and government actors. 
According to Etzkowitz and Leydesdorff (2000), systems of innovation should be 
viewed as the dynamics of change in systems of both production and distribution. 
In relation to the Triple Helix thesis, Etzkowitz and Leydesdorff (2000) view 
government involvement within the production puzzle as the main shift from the 
double to the Triple Helix; thus leading to the development of trilateral networks 
to help resolve social and economic problems.  
The juncture at which transformation is taking place exists at the level 
which the roles and processes of each can be carried out by the other (Leydesdorff 
and Etzkowitz, 2001). As already discussed, the university shares industry roles 
through the creation of incubator facilities and new firms. The government 
assumes industry roles by funding new developments and providing regulatory 
oversight. Industry takes on academic roles by offering training and carrying out 
high-quality research. Although they still operate individually, the closer relations 
is creating interdependency between the institutions (Leydesdorff and Etzkowitz, 
2001).     
The MF LOC device fits nicely under the Triple Helix model as it 
involves input from academics, government and industry. The government’s role 
is to provide funding through organizations such as the Canadian Institutes of 
Health Research (CIHR) and Canadian Foundation of Innovation (CFI) for 
research and to develop technology. Academics and other researchers from 
industry collaborate to develop the technology. This unification of institutions 
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signifies a shift in the new production of knowledge in so far as different 
groups emerge within the arena to contribute to the social and technical 
development of an emerging technology. 
Etzkowitz and Leydesdorff (2000) posit that the contribution of science to 
the economy has driven international competition for science development. 
Science and knowledge-based growth are increasingly identified as key drivers of 
an economically robust nation. It was not until recently that the place where 
research was conducted became a concern. The view that the location of 
science/knowledge production is not connected to a first adopter’s advantage is no 
longer a strongly held notion. Etzkowitz and Leydesdorff (2000) refer to Silicon 
Valley as a case in point whereby an expansion in information technology led to a 
large increase in economic activity in that region.  
The main impetus now for legitimating scientific research is not 
essentially based on military or health objectives, but rather on the contribution 
that the research would have on economic development. Etzkowitz and 
Leydesdorff (2000) maintain that the university can remain as the core institution 
of knowledge development so long as it keeps to the primary mission to 
“educate”. A university’s competitive edge is found in the flow of “human 
capital” whereas corporations are more static with respect to the throughput of 
workers contributions: “The turnover of students insures the primacy of the 
university as a source of innovation. The universities unique comparative 
advantage is that it combines continuity with change” (Etzkowitz and 
Leydesdorff, 2000: 118).    
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The establishment of a global economy has created a need for 
institutions within nations to pool their resources and to collaborate in order to be 
competitive with the rest of the world; thus, also supporting the links between 
university, government and academia. In order for countries to be innovative, 
university-industry-government relations need to change to align to the new 
economic goal. According to Leydesdorff and Etzkowitz (2001) regardless of 
whether a country starts with state control of incorporating industry and academia 
towards a shared developmental goal, the end result is that these institutions are 
all gravitating towards a common direction. The Triple Helix thesis combines the 
following three areas which can be found amongst the network relations in 
various countries:  
1. The action in the market place in regards to what individuals are 
interested in. 
2.  Internal dynamics between companies and an exposition of 
what each company is doing.   
3. Governance of the interface of relations between university, 
government and academia (Etzkowitz and Leydesdorff, 2000).  
The argument put forth by the Triple Helix model is that the dynamics 
between university, industry and government are essential for enabling the 
progress of innovation in a knowledge-based society (Etzkowitz and Leydesdorff, 
2000). However, in looking closer at the Triple Helix thesis of innovation an 
irony emerges in recognizing that there is no independent regulatory system 
outside these institutions to address the ethical, social and legal considerations 
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flowing from emerging technologies; in fact, such issues are often deemed to 
be non-regulatory. In establishing the linkages there also emerges a sense of co-
dependence, and thus the success of one institution depends on the success of 
others. As universities and governments become more concerned with the agenda 
of the corporate world the ethical, legal and social discussions may be 
jeopardized. 
Although the Triple Helix model is conceptualized by Leydesdorff and 
Etzkowitz (2001) as “multi-structural” and “multi-functional,” the inclusion of 
other types of “softer” productions of knowledge are lacking such as cultural 
values and ethical discourses. The Triple Helix model exists to describe the 
current state of knowledge production and the process of innovation, and does not 
account for the production of ethical and social knowledge surrounding the 
implications of emerging technology applications. Regardless of this shortfall, 
evidence of the Triple Helix thesis can be found in Canada from collaborations on 
scientific tools as small as lab-on-chip devices to as large as synchrotrons. The 
trend of universities partnering with industry and government to incorporate 
research with commercial purposes supports the Triple Helix thesis. A clear 
illustration of this can be found in Saskatoon, Canada, in the development of the 
Canadian Light Source (synchrotron) which is partly funded by government, 
owned by the University of Saskatchewan, and is open for industrial use. In 
Saskatoon a strong trilateral knowledge cluster has also emerged in relation to 
biotechnology. The University of Saskatchewan is at the core. A government 
agency, Agriculture and Agri-Food Canada, is on campus and Innovation Place is 
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also on university grounds and proclaims itself as one of North America’s best 
research parks.  
The critical downside of these links is that the public’s already skeptical 
views of industry motives may further jeopardize public trust in government and 
academia if the boundaries increasingly blur between these institutions. If MF 
LOC devices are commercialized without proper social and ethical consideration 
for individual rights, this will further diminish the public trust in the governance 
of emerging technologies in general. Building a strong capacity to assess the 
ethical, legal and social issues independently from ulterior motives is imperative 
to monitoring transformative technologies such as MF LOC devices. 
 
2.3 POST-MODERNISM/POST-NORMAL SCIENCE AND KNOWLEDGE 
PRODUCTION  
A post-modernist response to how we know what we know, how 
knowledge is produced, and what constitutes science differs from traditional 
practices (Rosenau, 1992). Most post-modernists would reject the Mode-2 and 
Triple Helix approaches to knowledge production since both approaches still 
adhere to a rational objectification of knowledge. A skeptical post-modernist 
disagrees with contemporary versions of science, epistemology and methodology 
(Rosenau, 1992). Affirmative post-modernists opt for a reformative approach 
rather than an abolishment of scientific methods.  
 Post-modernists declare an end to all paradigms and in doing so they reject 
the Kuhnian (Kuhn, 1970 as cited in Rosenau, 1992) model of science which 
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relegates knowledge to a stream of successive paradigms (Rosenau, 1992). 
Rosenau (1992) claims that a major problem with post-modernist epistemology 
and methodology is that in the end anyone can say what they want and claim 
equal validity. “Anything” can range from fascination to out right absurdity, and 
post-modernists have no way to differentiate between the two (Rosenau, 1992).    
Many post-modernist thinkers reject representation. Representation is 
viewed as a tool of modernity to form social organizations and political structures. 
Rosenau (1992) uses a variety of words to put representation into context: 
delegation (individual representation in parliament), resemblance (painting), 
replication (photograph or image), repetition (words in writing), substitution 
(lawyer), duplication (photocopy represents the original). Affirmative post-
modernists agree on the following: “a rejection of modern science, a questioning 
of the modern idea of progress, a refusal to affiliate with any traditional 
institutional political movements that have what they consider a ‘totalizing 
ideology’ and an abandonment of logocentric foundational projects with 
comprehensive solutions – be they liberal centrist or conservative” (Rosenau, 
1992: 144). 
 Many affirmative post-modernists like the idea of a public sphere that is 
independent of the private sphere in which citizens can through deliberations 
come to a consensus. This is very close to Habermas’ (Braaten, 1991) articulation 
of a public sphere that can partake in political and social discourse. The aim of the 
public sphere is for individuals to come to a consensus that reflects the common 
good in the form of an open public forum.  At least the affirmative post-
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modernists vie for a revitalization of the public sphere to lead to better 
democracy. The skeptical post-modernists, however, disagree and believe that a 
consensus is not possible. 
  Some theorists say that the differentiation between the public and private 
sphere is blurring. Skeptical post-modernists reject the exchange of discourse 
within a public sphere and promote subjective private experience as reality. They 
also reject the public sphere because it “assumes the possibility of effective 
intersubjective communication” (Rosenau, 1992: 104). Also the public sphere is 
viewed by skeptical post-modernists as aligned with rationality and reason.  
 The merging of the public and private spheres is thought to be a reason for 
the emergence of post-modernism (Rosenau, 1992). The rise of consumerism and 
a dependence on the private sector for meeting consumer demands may have 
caused the individual to turn away from the public sphere and be more self 
reflexive in everyday life concerns (Rosenau, 1992). But skeptical post-
modernists argue that the private sphere is also disappearing and leaving nothing 
but a void thus allowing post-modernism to thrive (Rosenau, 1992). 
Given the skeptic’s belief in the demise of a viable public sphere, the end 
of history, the absence of truth and the death of the author (as a 
responsible agent) it is not surprising that they might refuse to advocate 
action, that they are anti-participatory or indifferent with respect to politics 
(Rosenau, 1992: 139). 
 
It is unclear how the post-modernist would come to agree on a socially 
responsible form of governance that took into account the social, legal and ethical 
dimensions of emerging technologies. Affirmative post-modernists do contend 
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that an open more involved public sphere would contribute to more direct 
forms of governance; however their discussion on controlling risk is minimal. 
Skeptical post-modernists do not even come close to evaluating ways of dealing 
with governance since they believe that individuals should be discouraged from 
participating in governance. The existing framework for managing innovations 
within a knowledge economy is not always sufficient for addressing new 
emerging technologies. The government’s responsibility for regulating and its 
duty for safety of citizens sometimes conflicts with obligations of national 
economic growth. On the one hand, the government is expected to help encourage 
a growing and vibrant economy, while at the same time it is expected to ensure an 
optimal risk free society for citizens.     
The dual role of government as both promoter and regulator of science and 
technology may lead to the public’s loss of faith in the government’s role as 
regulator. Although agencies that do the regulating and promoting are separate 
entities under the government umbrella, public perceptions of these conflicting 
roles creates an environment of innovation controversy. In the case of genetically 
modified wheat, Agriculture and Agri-Food Canada (AAFC) partnered with 
Monsanto Inc. to develop a new modified variety of genetically engineered wheat 
such as Fusarium resistant wheat. Public organizations such as the National 
Farmers Union and Network of Concerned Farmers were apprehensive by this 
partnership and criticized the government of being “in bed” with industry 
(Stratford Beacon-Herald Newspaper, 2003). The government’s defense was that 
the Canadian Food Inspection Agency and Health Canada are government 
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organizations that oversee the regulation of food safety. As a result, the 
disruption of public trust in government has led to the need for more stringent 
regulatory frameworks and risk management systems. De Marchi and Ravetz 
(1999) warn that the breakdown of trust in regulatory institutions could inevitably 
dampen technical innovations and public confidence in government. Regulatory 
institutions need to become more transparent and include a more rigorous regime 
in risk management. De Marchi and Ravetz (1999) propose the use of a new 
regime that includes applying principles from a Post-Normal Science approach.  
 
2.3.2  POST-NORMAL SCIENCE 
Initially, risk management was in the domain of the laboratories and 
mainly at the site of application, this is reminiscent of the Mode-1 type of 
knowledge production. Due to advances in technologies that produce significant 
uncertainties, the role in governance of risk and social, ethical and legal domains 
is expanding. This expansion as noted by De Marchi and Ravetz (1999) requires a 
Post-Normal Science (PNS) approach that takes technological uncertainty into 
consideration for decision-making. 
Post-Normal Science was initially conceptualized through the increasing 
pathologies of the industrial system (Ravetz and Funtowicz, 1999). PNS emerged 
to understand the importance of scientific developments primarily in the 
information technology (IT) and biomedical sectors, and the potential for 
damaging consequences to emerge from technical applications. Ravetz and 
Funtowicz (1999) further characterize PNS as a focus on the quality of processes 
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between science and society and the lessening of bias towards exclusive 
technocratic ideologies that anything “scientific” is value-free. There is an 
emphasis on industrial risks, “A most important task in the articulation of PNS is 
locating it in its context in contemporary social theory of industrial society” 
(Ravetz and Funtowicz, 1999: 644). De Marchi and Ravetz (1999) use several 
examples to illustrate the evolution and further need for industrial risk 
management.   
 De Marchi and Ravetz (1999) explain that in order to employ risk 
managers there needs to be an understanding of the complex nature of the task. 
The number of individuals involved is extensive: “As a risk issue goes through 
the cycle from first announcement through to public debate, identification, official 
acceptance, quantification, then legislation and/or regulation, and finally 
monitoring, a great variety of actors are involved, in a multiplicity of contexts,” 
(De Marchi and Ravetz, 1999: 744). No one perspective should prevail. 
 Trust is an essential element in risk management, especially in addressing 
the ethical, legal and social implications of emerging technologies and the use of 
new production processes. De Marchi and Ravetz (1999) built on the cases of the 
“Seveso” accident (dioxin cloud), the bovine spongiform encephalopathy (BSE) 
crisis, and the introduction of genetically modified (GM) maize. In their research 
they methodically show the unraveling of risk issues and the responses by 
government and other regulatory institutions in an attempt to console and reassure 
the public of safety. What follows is a brief review of the case studies examined 
by De Marchi and Ravetz (1999). 
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Case studies: De Marchi and Ravetz (1999) used Seveso to analyze the 
response to accidents that occasionally take place. The BSE incident was 
highlighted to understand an essentially human-made disease that has no 
measurable incidence; and the issue of genetically modified organisms, was 
drawn on to illustrate the issue of GM maize as a hypothetical risk. 
a) Seveso. The Seveso case was viewed by De Marchi and Ravetz (1999) 
as an evolutionary construction of a regulatory system. The incident occurred 
from a factory accident that released a poisonous cloud that contained dioxin. 
Although the long term epidemiological monitoring of individuals potentially 
exposed to the dioxin cloud did not lead to any real conclusive evidence of mass 
harm to human health, the social-political response was far-reaching. De Marchi 
and Ravetz (1999) symbolically equate Seveso with accidents such as Chernobyl4  
in mobilizing concern about risk governance and loss of public trust. The 
awareness of the Seveso hazard pre-empted the establishment of a European 
framework of regulation that sought for the harmonization of prevention and 
protection measures relating to hazards in Europe.  
b) Bovine spongiform encephalopathy. This pathology is believed to have 
originated from the feeding of sheep remains to cattle. Regulations at the time 
 
4 “The Chernobyl accident in 1986 was the result of a flawed reactor design that was operated 
with inadequately trained personnel and without proper regard for safety. The resulting steam 
explosion and fire released at least five percent of the radioactive reactor core into the atmosphere 
and downwind. 28 people died within four months from radiation or thermal burns, 19 have 
subsequently died, and there have been around nine deaths from thyroid cancer apparently due to 
the accident: total 56 fatalities as of 2004” (World Nuclear Association).  
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allowed for the rendering of animal carcasses. Since then an advisory 
committee was established and it was recommended that brains, spinal cords and 
other organs were not to be used. The recommendations by the committee were 
not taken seriously, and in 1995 a human variant of spongiform encephalopathy 
was found in the form of Creutzfeld- Jakob disease. This created a media frenzy 
which ended in a ban by the European commission on British beef. 
c) Genetically modified (GM) maize. The introduction into Europe of GM 
maize was met by contestation not on grounds of quantifiable risk but by 
hypothetical risk and uncertainty backed by an increasingly suspicious public. “In 
one sense, the risk of this GM maize is ‘post-modern’ in that there is no palpable 
or even demonstrable injury,” (De Marchi and Ravetz, 1999: 752). The risk of 
GM maize is also “post-normal” in the sense that food retailers and NGO’s have 
aligned themselves to develop a voice for mass consumer action which 
contributes to the “extended peer community.” 
  De Marchi and Ravetz’s (1999) comparison of the cases show that the 
“Seveso” incident resembles a shift in the philosophies and management of 
significant accident hazards. The BSE crisis reveals the need for transparency in 
the development of risk management. The novel challenges of GMO’s pose 
unsolved problem in the governance of hypothetical risks. The uncertainty of 
hazards from biotechnology requires new forms of governance. According to De 
Marchi and Ravetz (1999), in the absence of reliable scientific evidence, the 
trustworthiness of government and authorities becomes paramount and requires 
the participation of the public. “In the terms of post-modernity, in such policy 
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debates there is no ‘grand narrative’ of scientific objectivity which protects the 
experts’ assertions from doubt and criticism” (De Marchi and Ravetz, 1999: 755).  
The introduction of novel hazards with high levels of uncertainty creates 
unique challenges for regulators. According to De Marchi and Ravetz (1999), the 
successes of science-based technology have now created problems which science 
can not solve without help. The inclusion of other voices outside of the expert 
domain is needed in order to help with decisions regarding the application of 
potentially hazardous technologies. The lack of serious reforms in regulation in 
the light of new advances in technology could lead to a depletion of public trust in 
government regulations. The solution according to De Marchi and Ravetz (1999) 
lies in a Post-Normal Science that utilizes the voices of “extended peer 
communities” through focus groups, citizens juries, consensus conferences or 
stakeholder forums. “Such an enrichment of the peer community would be central 
to the implementation of a program for ‘knowledge assessment’ in relation to 
risks and environment or health hazards” (De Marchi and Ravetz, 1999: 756). The 
success of MF LOC devices will also hinge upon the incorporation of a proper 
assessment of the human health and social impacts of other potential uses of MF 
LOC devices such as for employee selection and insurance evaluation. 
 
2.3.3 POST-NORMAL SCIENCE AND THE PRECAUTIONARY 
PRINICIPLE    
 
 Ravetz (2004) suggests that science is in a new troubled situation in that it 
must deal with issues of confidence, legitimacy and power. Ravetz (2004) divides 
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science into two arenas, “the mainstream” which is connected to industry and 
the “post-normal” which is linked to the precautionary principle5.  Ravetz (2004) 
explains that the dimensions of Post-Normal Science include relying on public 
debates and extended peer communities. Post-Normal Science questions the value 
system that comes into play in all science, even statistics. Ravetz (2004) claims 
that Post-Normal Science is necessary in times of uncertainty, or when decision 
stakes are high. Traditional normal science is not effective under conditions of 
uncertainty, and Ravetz (2004) views Post-Normal Science as the “extension of 
democracies appropriate to conditions of our age,” (347). In applying the PNS 
approach to MF LOC devices, the course of action may be to allow for the 
development of technology to continue. Before reaching the point of 
commercialization, however, the precautionary principle should be exercised until 
an adequate assessment of the social, ethical and legal impacts are complete.   
Tognetti (1999) describes PNS as a constructive and creative method to 
understand issues concerning sustainable development without adopting strictly 
technical solutions. Diversity is key as it provides choices and flexibility; 
however, science still has an important part in contributing valuable information 
for decision-makers regarding ecological information.  
 Ravetz (2004) also gives credit to science as the “great driving force of 
modern global civilization” (347). He states that industrial society has progressed 
 
5 The precautionary principle as stated by the 1990 Bergen Declaration of European Ministers: In 
order to achieve sustainable development, policies must be based on the precautionary principle. 
Environmental measures must anticipate, prevent and attack the causes of environmental 
degradation. Where there are threats of serious or irreversible damage, lack of full scientific 
certainty should not be used as a reason for postponing measures to prevent environmental 
degradation (Levidow, 2001).  
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on the principle that technologies are safe until proven dangerous. The 
precautionary principle, which Ravetz advocates, is in many respects the opposite. 
Ravetz (2004) claims that although great resistance will be met when 
implementing the precautionary principle, the need for change is inevitable. 
“When environmental and health policies involving science are debated, in place 
of facts we have uncertainty and even ignorance. We can no longer separate 
‘nature’, ‘science’, and society” (Ravetz, 2004: 348). This is especially evident in 
the ‘new genetics’ as the use of scientific methods to identify nature are exploited 
and come to be understood as a means of understanding who we are as humans.  
 Ravetz (2004) makes the connection that the dismantling of the state’s 
hold on scientific expertise has repercussions on a state’s authority of governing 
society. “The ideology of modern science has become the rationale and 
justification of modern government” (Ravetz, 2004: 348). And as such, scientific 
expertise has replaced divine authority, birth, and wealth as a legitimate rule for 
governance (Ravetz, 2004). But now this form is facing its own legitimacy issues. 
Many scientists want to stay out of the lime light of decision-making, but are 
certainly aroused if decisions are made that impact their research.  
 Mainstream science carries the attitude of inevitable progress, and Ravetz 
(2004) postulated that as mainstream science delves more into molecular genetics 
the engineering of life itself becomes the norm, but not without risk uncertainties. 
The race to progress has unloaded the issues of safety and ethics onto regulatory 
bodies. For example, the cloning of humans has been an ongoing lively debate for 
the last five years. Discussion to legislate against human cloning and to make it 
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illegal created a discourse among many scientists claiming that if they were not 
able to do the research in their country then they would move to a country where 
it was legal. Clearly, there is a fine line between regulating research and upsetting 
the knowledge production process. 
 With respect to advancements in nanotechnology it will be even more 
pertinent to establish clear understandings of the social, ethical and legal 
implications so that decision makers can be better equipped to facilitate peaceful 
progress while deterring unwanted risks and hazards. The Center for Responsible 
Nanotechnology has established a Global Task Force on implications and policy 
relating to developments in nanotechnology. The Task Force was officially 
announced in August 2005. In a fashion reminiscent of Post-Normal Science 
ideology the Task Force is made up of  “experts” from multiple disciplines to 
establish a holistic account of safe and responsible use of nanotechnology. In an 
attempt to conceptualize these challenges the Task Force has asked experts to 
contribute various essays addressing questions of risk: what risks do we really 
face? How do they relate to each other? And what is most important to know in 
order to design wise and effective policies for molecular manufacturing?6
 Ravetz (2003) claims that governments in many parts of the world face 
current dilemmas in offering security and safety to the public due to the 
emergence of controversial technological innovations. Ravetz (2003) attributes 
the crisis to the structural dynamics of the global knowledge economy and the 
dual roles of government as both promoter and regulator of technological 
 
6 Website can be found at: http://crnano.org/CTF.htm  
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enterprises. Ravetz (2003) seeks a reconciliation of technological dilemmas 
through the recognitions of critical policy and the employment of a Post-Normal 
Science approach. 
  
2. 4 AN AMALGAMATED MODEL OF KNOWLEDGE PRODUCTION  
The single accounts of Mode-1, Mode-2, Triple Helix and PNS do not 
provide a holistic description of the new modes of knowledge production and 
praxis for the social and ethical governance of new emerging technologies. I 
believe that a combination of the Mode-2 and Triple Helix thesis can best 
describe the current status of knowledge production processes while PNS 
contributes by suggesting some guiding principles by which the governance of 
emerging technology may benefit from.  
Figure 1. Amalgamated Model of Knowledge Production 
Post-normal 
Science
Mode-2
Knowledge 
production
Triple Helix
Knowledge
production
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Praxis towards building 
capacity for governance
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Figure one illustrates how Mode-2, Triple Helix and PNS all operate 
within separate spheres and yet can contribute to providing a fuller picture of the 
current knowledge and innovation processes and the importance of governance. 
Weakness in one model are strengths in another. *The crux of influence refers to 
the center point where the models come together to contribute theoretical 
characteristics that both describe the current modes of knowledge production and 
provide a praxis for socially responsible governance.    
Shinn (2002) analyzed Mode-2 and the Triple Helix thesis and found that 
neither of them took into account that university, industry and government all 
operate from a national perspective. Where the two theories unite is in the search 
of “transversality”, essentially the intersection and integration of cognitive, 
technical, economic and societal boundaries (Shinn, 2002). The Triple Helix 
model emerges as a sociological analysis of the knowledge-based social order that 
emphasizes historical continuities and examines the groups from university, 
government and academia that emerge to take on social/technical problems 
(Shinn, 2002).  Mode-2 theory does not put forth questions, methodologies, or 
answers but rather unravels its discourse in a fashion similar to a rhetorical 
political manifesto (Shinn, 2002). 
Although Mode-2 theory is weakened by positions that the university’s 
role is decreasing, it does have a relevant stand point in regards to the 
heterogeneity of actors involved in knowledge production and the identification of 
the transition from basic to applied research and development. I also would adopt 
Gibbons (1999) later thinking on socially robust forms of governance which 
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includes a reflexive scientific community and the public in the discourse of the 
knowledge production process. The Triple Helix thesis picks up where Mode-2 
theory lacks, and includes universities as vital components of knowledge 
production. Especially, in the case of MF LOC, one can analyze the trilateral 
networks that have emerged in the social/technical development of this new 
technology amongst actors in university, government and industry. 
 A post-modernist account of knowledge production is elusive with the 
exception of Ravetz’s (2003) Post-Normal Science theory. Post-Normal Science 
takes into consideration the expansion of democracy by encouraging public 
participation in the discourses and debates of modern-day issues in science and 
technology. PNS also extends the peer community to other experts and players to 
take an active role in the decision-making process. The application of the 
precautionary principle is another vital component of PNS, which according to 
Ravetz (2004) is necessary for today’s critical examination of emerging 
technologies before they are applied. Although application of the precautionary 
principle can be a little critical of technological progress, it is a useful tool to 
employ before commercially releasing MF LOC devices for the purposes of 
genetic analysis.  
 In essence, the combined model would include a socially robust form of 
governance that would take into account a variety of different factors including: 
1. Network analysis of industrial, academic and government institutions 
2. Transversality (referring to an integration of the cognitive, technical, 
economic and social contingencies)  
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3. Historical continuities (analysis of past success and failures) 
4.   Heterogeneity  (inclusion of various actors in development/decision)                      
5.   Reflexivity (thorough contemplation of actions and implications) 
6.   Public participation (inclusion of public perceptions and concerns) 
7.   Precautionary principle (better safe than sorry principle) 
Synthesis of the above mentioned components will foster better technical 
and social governance of emerging technologies. Understanding the linkages 
between university, government and industry is vital for comprehending the forms 
of knowledge production. Transversality is important in assessing societal 
consciousness and the technical and social boundaries within society. It is equally 
important to take historical trends and mistakes into account when determining 
present and future actions, and thus the utilization of a reflexive regime is also 
essential. Public participation is important in building trust between the public and 
institutions of research and development and governance. If there is doubt and 
risks are high, an application of the precautionary principle should allow for a 
socially responsible form of governance that will ensure the safety and well-being 
of affected individuals. 
Combining the strongest elements of each theory of knowledge production 
will create a theoretical tool that will enable society to progress technologically 
and socially, while maintaining individual rights and freedoms. It is evident that 
understanding the transformations of new scientific knowledge production will 
allow for a more effective socially responsible form of governance of new 
emerging technologies. The actors involved in developing and forming the 
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legalities and policies around the MF LOC device will benefit by 
contemplating these theories of knowledge production, and by thinking critically 
about the ethical, social and legal issues surrounding the possible applications of 
microfluidic lab-on-chip devices.   
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3.0 CHAPTER THREE: SCIENCE AND THE LAW 
The previous section provided a background to several theoretical 
orientations of current characteristics pertaining to the production of knowledge 
and technology. What was not discussed was the issue of laws and regulations 
regarding the application of new technologies. The social ramifications of the 
institutionalization of the MF LOC device into the workplace or within the 
insurance industries may set a precedent for the largest sanctioned discrimination 
act if laws are not developed to ensure that individuals are not being discriminated 
against based on their genetic profile. The emergence of critical fields such as the 
sociology of science and knowledge provides an avenue to critically analyze the 
use of technologies in society. The aim of this section is to discuss how the MF 
LOC device, may impact traditional practices, affect the privacy of individuals 
and contribute to genetic discrimination. Issues that will be addressed include the 
electronic storage of patient information and privacy rights. I will also look at 
lessons to be learned from past technologies and the relationship between science 
and the law. The thesis guiding this section is that it is important to consider who 
might use the technology and how that might impact certain groups of individuals 
 
3.1  SOCIOLOGY OF SCIENCE AND KNOWLEDGE  
 Since the 1970s the sociology of knowledge has started to incorporate the 
production of science into social analysis (Collins, 2002). This revolution, 
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according to Collins (2002), reflects the transformation in thought that took 
place in the west in the 1960s.  A major change that emerged within the sociology 
of knowledge was the concept of not taking a true or false stance pertaining to the 
phenomenon under social analysis. This paradigm shift allowed for an exploration 
of how scientific knowledge becomes legitimated.  
 Collins (2002) reports that the central focus of the sociology of knowledge 
is that although individuals adopt certain truths about their world, it is really only 
by chance that they were brought up in a particular society and thus understand 
things in a particular way. In other words, religious or political truths depend 
upon the societal context. The development of science itself is seen as largely 
socially situated. What Collins (2002) fails to examine is the cross-cultural 
phenomenon of science. Although each culture may differ in their methodology, it 
seems that understanding the mechanisms of nature is a universal phenomenon. 
Indigenous, and feminist knowledge also lends itself to uncover truths of the 
nature of things. A key difference between Collins’ (2002) understanding of 
knowledge as socially constructed and the shared universal phenomenon of 
seeking to understand the mechanisms of nature lays in the transition of applying 
science to technology. The ability to manipulate matter with precision down to the 
atomic level (nanotechnology) is a feat unprecedented in history. Although the 
development of progressive technology is a cross-cultural phenomenon to some 
degree, it is not practiced in all cultures. In economic-based (predominantly 
Western) societies, advances in science have led to progressive leaps in 
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technology and it has become increasingly important to develop laws to 
maximize benefits to society while minimizing harms.  
 Collins (2002) discusses Kuhn’s (1970) contributions to the understanding 
of scientific knowledge and credits Kuhn as the inaugurator of viewing science in 
the context of paradigm shifts. Scientific knowledge came to be seen as a creation 
from culture as much from nature.  I would argue that the development of the MF 
LOC technology does represent a Kuhnian paradigm shift as it allows the analysis 
of genetics to become further institutionalized due to the simplicity, size and 
decreased cost in comparison to traditional laboratories. Because of the intricate 
relations between this technology and its potential for (constructed or otherwise) 
human description and identification, it is imperative to understand the role of the 
law in regulating this technology for the best interests of individuals and to ensure 
individual freedom from genetic discrimination. 
 I do not discount the social construction of genetics, but it is equally 
important to acknowledge real-world applications of this technology and 
concomitant social impacts.  The remainder of this section provides a critical 
analysis of lab-on-chip technology, its relation to knowledge production, and the 
role of the law in technology application. I draw on past examples of how the 
application of certain technology has clashed with the law, and I make the 
argument that it is imperative to ensure that laws are created in tandem with new 
developments in technology. One of the issues at the forefront of genetic analysis 
technology is the rights of patient confidentiality and the storage of patient 
information. 
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3.2    STIGMA, DISCRIMINATION AND PATIENT PRIVACY  
 Medical privacy is a serious concern for patients. As the capacity for 
electronic storage of data increases, and the tools to mine data become more 
refined, the question of secure storage of patient data emerges at the forefront. As 
the past illustrates with accidents such as Chernobyl, technology can fail and 
when it does it can be devastating. Although patient records do not seem to be as 
threatening as nuclear accidents, it can prove to be as problematic. The use of MF 
LOC devices will enable a scaling up of collecting genetic profiles of individuals 
that will likely be stored in digital format. If accurate measures are not taken to 
ensure the safe storage of these data files, a number of problems could emerge. 
Such as doctors inability to access patients information due to system failures. 
Also, if accidental deletions of key pieces of patient information occurred, this 
could result in a tragic situation for patients. For example, if a patient is intolerant 
to penicillin and this information is lost from their file then it puts the patient at 
risk if health care workers administer penicillin.  
 Alpert (2003) warns that the increasingly detailed information about a 
patient’s genetic profile could be risky for the patient if information was obtained 
by potential (or current) employers or insurance companies. Advances in 
communication technology allow for easy information transfer to health care 
providers, hospitals and employers, leaving the patient vulnerable to others 
knowing their personal information (Alpert, 2003). It has been an ongoing debate 
as to whether employers or insurance companies should have access to this data. 
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As of yet there are no laws in Canada prohibiting employers or insurance 
agencies from using genetic information in their selection process. 
 The propensity for stigmatization and discrimination exits and will only be 
amplified if MF LOC devices are commercialized and available for general use. 
Stigma is defined by Goffman (1963) as a trait that labels the carrier with a 
“spoiled social identity”. Lujan and Moreno (1996) defined genetic discrimination 
as acts or gestures against an individual or against the members of a family 
regardless of whether the differences are real or perceived in relation to the 
“normal” genome.  
 Carrying out genetic tests on individuals will inevitably increase labeling 
and thus stigmatizing. Once a stigma becomes recognized (in the case of genetic 
testing the stigma would be associated with genetic abnormalities) the process of 
discrimination can occur thus leading to acts against certain individuals or groups 
of people.  
There are four main purposes for carrying out genetic tests: identification 
of carriers, prenatal diagnosis, pre-symptomatic diagnosis and DNA profiling 
(Lujan and Moreno, 1996). Lujan and Moreno (1996) further characterize the 
impacts of genetic testing according to whether they are used in clinical or non-
clinical contexts. The non-clinical areas of concern are in the domains of 
purchasing life insurance and in the work force. Insurance agencies would 
probably use the genetic information to reduce risks of insuring potentially high-
risk clients, and companies may use genetic testing to select out employees who 
might be predisposed to certain diseases which would lead to absence, loss of 
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productivity and increased corporate coverage of medical care (Lujan and 
Moreno, 1996).  
 In the United States, congress has on numerous occasions dealt with 
medical privacy issues, but as of yet no agreements have been reached as to the 
extent of the medical privacy act. At stake as well is patient compliance and a 
willingness to divulge information to their physicians. In the US, federal laws 
only protect patient information relating to substance abuse and mental health 
(Alpert, 2003). 
 One of the Mandates under the Health Insurance Portability and 
Accountability Act 1996 (HIPAA), is to improve the efficiency of health care by 
implementing the electronic transmission of health information (Alpert, 2003). 
Also included under HIPAA was a five year grace period before the inclusion of 
legislation or regulation of federal protection for medical records. However, there 
was not enough time for congress to develop privacy legislation, and it continues 
to be at a standstill (Alpert, 2003). 
 The inclusion of genetic analysis is not something that is currently in 
patient-medical records; however, it may soon become part and parcel of each 
patients’ medical profile (Alpert, 2003). A major concern with describing an 
individual’s genetic code is that even if one possesses a gene for a certain disease, 
it does not necessarily mean that the person will develop the illness, it only 
predisposes them. Since it is false to espouse a genetic determinist position, then 
it is even more important to develop sensitive guidelines around genetic 
discrimination. The other concern of including a genetic profile in everyone’s 
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medical file is that it essentially labels all at risk to some degree to an ailment. 
The psychological impact of learning that you are predisposed to certain diseases 
would be difficult to measure. It should also be a patient’s right to not obtain 
knowledge of their own genetic profile.  
Everett (2003) argues that ‘genes’ as we have come to know them today, 
have taken on a “social life of their own”. Although federal agreement on medical 
privacy laws has turned up inconclusive, there are a number of states in the US 
such as Oregon that have constituted a Genetic Privacy Act (Everett, 2003). This 
Act gives individuals inalienable property right to their own DNA.  Everett (2003) 
contends that both sides of the debate, of who should own property rights to 
DNA, display a property metaphor that relegates genes as part of the human body 
to something similar to a commodity. This approach neglects the veracity of the 
body (Everett, 2003). The evolution of scientific knowledge and its relation to the 
law are central to understanding how genes become commoditized. Everett (2003) 
acknowledges that recombinant DNA-based technology, and changes to patent 
law, are monumental, but just as colossal is generating wealth from the body.  
  Everett (2003) reports that in a survey of 1500 genetic counselors and 
physicians there were 785 cases where patients had lost their job or insurance 
coverage due to a genetic condition or test. In another survey by the American 
Management Association, about 30% of mid-sized to large companies used 
genetic information from employees and 7% admitted to using information in the 
selection process and in promotion decisions (Everett, 2003).  Currently, 33 states 
have developed legislation to help prevent genetic discrimination in regards to 
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health insurance, and 19 states have legislation against employee 
discrimination. Although the progression of some state laws is a good start, it 
does not suffice for the whole of the nation in the US. Also, Canadian laws are 
lagging behind in addressing the issue of patient privacy and genetic information. 
Addressing the limitations of current laws and regulations is imperative to avoid 
genetic stigma and discrimination in society. 
 
 3.3  THE SCIENCE-LAW RELATIONSHIP 
  In the past, science and the law came into conflict whenever scientific 
search for the truth collided with the laws sense of justice (Jasanoff, 2001). Law 
and science share an intricate relationship since the beginning of modernity; 
however, the relationship between science and law changed by the end of the 
1900s (Jasanoff, 2001). Different perspectives were divided on the issue of how 
legal institutions should interact with scientific experts. Just as science has 
introduced new ways to handle the law, the law has also influenced the extent to 
which science is carried out. It is now more imperative than ever to develop 
science and law in relation to one another.   
 The relations of science and law are so intertwined that they would 
essentially use each other, to some degree, to build up authority (Jasanoff, 2001). 
For example, the use of witness accounts was used earlier in science to reflect a 
type of truth.  In a democratic society science became a means of organizing 
disciplines and individuals. Science gave credence to the division of individuals 
into categories of normal, pathological, mainstream and deviant.  And the law has 
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evolved to reflect the norms of society such that deviant behaviours become 
‘outlawed’ and punished. In relation to science and technology, the use of risk 
analysis helps to incorporate necessary laws that enhance safety while 
diminishing harm. 
In looking at the law-science relationship, the 1990s emerged as a major 
turning point that sparked a view that the hybridization of law and science was of 
great interest to the public (Jasanoff, 2001). For instance the use of biological 
markers in DNA for the identification of criminals was co-developed with the 
legal systems input which provided the necessary context for the successful use of 
DNA identification technology with standardization and regulation.   
In the case of microfluidic lab-on-chip devices the incorporation of 
nanoscale components into the device signifies the integration of nanotechnology, 
biotechnology and information technology. The use of the device as a genetic 
testing tool, and for other biological analysis, poses questions that centralize 
around individuals livelihoods. It is with irony that MF LOC devices are being 
developed with the mission in mind to advance health care, but the misplaced use 
of that same technology in another institution constitutes a tool that imparts 
judgment against one’s livelihood. For example, if an employer uses the device in 
the selection process for potential employees, this could lead to a genetic divide 
between the so called “genetically normal” and “genetically defected”. The 
following scenario illustrates this point: 
Imagine during the next job interview you go to, the human resources 
personnel informs you that you will be required to provide a DNA sample for 
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genetic testing. You comply and watch as they deposit your DNA swab into the 
hand-held microfluidic lab-on-chip device which relays information to a desktop 
computer. Before you even get to the interview a genetic counselor informs you 
that you will no longer be a potential candidate for the position as you have been 
found to be genetically predisposed to Alzheimer’s or Huntingtons. As members 
in a society we need to ask ourselves if we are willing to be subjected to the 
slippery slope of genetic testing for the purposes of employee selection. In the 
biotechnology realm, farmers may be concerned about  corporations owning the 
right to create terminator seeds and to require the purchasing of new seeds every 
year, but corporations who have the right to select employees based on genetic 
profiles is more worrisome. There is a definite need for science, technology and 
law to collaborate in ensuring that ethical and social implications are taken into 
consideration before commercialization of a transformative technology such as 
MF LOC devices. 
 
3.4  SCIENCE, TECHNOLOGY AND RISK 
The area of risk analysis poses a fundamental focus on the hazards of 
industrial production. As technology advances it is important to ensure ongoing 
safety for  workers, consumers and the environment. The industrial relations 
between law and science can help safeguard against injury. However, conflict 
emerges when industry does not have sufficient safeguards in place, and the law is 
left to retrieve the pieces. For example, the commercialization of genetically 
modified Canola sparked organic farmers to legally challenge biotechnology 
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companies such as Monsanto and Aventis with law suits to compensate for 
contamination of organic crops and subsequent loss of market potential (Mehta, 
2005). Another example is asbestos workers and the manufacturers’ negligence in 
employee health. After many died and others were severely injured by asbestos 
exposure in mines or ship yards, a lawsuit was brought against the asbestos 
manufacturers which resulted in bankruptcy for the industry7. If laws and 
safeguards were in place in advance through proper risk analysis techniques than 
these types of episodes could be avoided. 
 The key is to embark on a rigorous and comprehensive risk analysis of the 
potential applications of a technology before it is too late. This is especially 
important before introducing new technologies such as GM products. The role of 
science in risk analysis is to come up with new methodologies and expressions of 
knowledge in order that instruments and processes can be developed to assess risk 
and employ preventative techniques. Beck (1999) claims that we are increasingly 
becoming a risk society and we need to practice reflexivity and caution with 
future technological endeavors. 
In his book, World Risk Society, Beck (1999) traces the origins of current 
global transformations to industrial developments and advances from the first 
modernity. Beck (1999) claims that we are now in a second modernity; the first of 
which focused on equal distributions of wealth, and the second modernity focuses 
on minimizing risk. 
 
7 For further information on asbestosis law suites:  
http://www.kazanlaw.com/practice/asbestoslit.cfm  
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The risks that are current today are a result of the unforeseen 
consequences of the successes of the first modernity (Beck, 1999). Beck 
differentiates the first modernity from the second modernity by placing the first 
modernity within the context of the beginning of the industrial era.  The second 
modernity is the current state of western society and it is now destabilized by 
globalization, individualization, gender revolution, underemployment, and global 
risks. The challenge now is to respond to these issues concurrently (Beck, 1999). 
MF LOC devices encompass global concerns to the extent that the device as a 
genetic analysis tool further substantiates the notion of genetic determinism. As 
individuals and organizations around the world become aligned and adopt the 
“perception” of genetics as a viable piece of knowledge that identifies who we are 
as a human, regardless of the truth of the claim, then the potential for genetic 
discrimination and stigmatization increases.   
 In this new era of risk assessment and risk-based policy formation, Beck 
(1999) encourages the involvement of non-western nations into the calculation of 
the world risk society. This is especially important since the risk impacts are no 
longer regionally located, the increase in global exports creates a potential for the 
wide-spread of risks. For example, if genetically modified wheat is developed in 
Canada, and it is later found to contain a modified protein that induces an allergic 
response, the devastation is potentially global in nature.  Beck (1999) states that 
we are in the midst of an ecological enlightenment stage and that individuals are 
increasingly aware of potential industrial and technological impacts on the 
environment.  
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The rise of non-governmental organizations such as Greenpeace and 
ETC Group demonstrates how the notions of risk and uncertainty are held in a 
technologically advanced society. The ETC Group, formerly known as RAFI, 
have railed against applications in biotechnology and now are directing their 
efforts to be critical of nanotechnology. They have published with a report 
entitled, “The Big Down: Atomtech-Technologies Converging at the Nano-Scale 
(2003)8. In the report they outline some of the dangers inherent to nanotechnology 
development and explore the stakeholders involved including actors from 
government and academic scientific institutions. A motive of the ETC group is to 
supply policy makers with recommendations for action, including a moratorium 
on all nanotechnology development.  However, I do not believe that curtailing the 
development of MF LOC devices is the answer. The use of MF LOC devices can 
have beneficial applications as in the use of cancer diagnosis and disease 
monitoring. But as with many things, with the good comes the bad; and it is 
within our human potential to control for negative consequences while harnessing 
the benefits that will allow health technology to evolve in an effective manner.   
Beck (1999) acknowledges that the boundary between the scientific 
laboratory and society is disintegrating. Beck claims that the conditions of 
freedom have shifted, “Freedom of research implies freedom of application” 
(Beck, 1999: 61). Meaning that today there are few controls that exist for the risks 
from a scientific progress. “The main question is how to take decisions under 
conditions of manufactured uncertainty, where not only is the knowledge base 
 
8 To access the ETC article go to: http://www.etcgroup.org/article.asp?newsid=375  
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incomplete, but more and better knowledge often means more uncertainty” 
(Beck, 1999: 6). A range of actors such as government, industry, and non-
governmental organizations have emerged to partake in what Beck refers to as a 
sub-political environment. Within the sub-political environment it becomes hard 
to discern who is doing the decision-making. 
 
3.4.1 LESSONS FROM THE PAST 
Those who develop, regulate and study emerging technologies can learn 
from the experiences of nuclear power and biotechnology.  The accident at 
Chernobyl not only had a physical consequence, but also impacted on public trust. 
The public has increasingly become skeptical of the applications of technology.  
The inclusion of genetically modified organisms in much of today’s processed 
food has brought forth concerns from many consumers. The lack of labeling on 
such products disrupts a contract of informed choice between consumer and 
producer, and the withholding of information is viewed by many consumers as 
irresponsible on the part of industry.  
In Canada, Bill C-287 was introduced to make labeling of GM products 
mandatory; it was defeated in October, 2001.  Industry fought back arguing that it 
would require too many resources that would eventually be reflected in consumer 
cost. Instead of making labeling mandatory, the outcome was a five year period of 
voluntary labeling with the possibility of mandatory labeling laws at the end of 
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the five year period9. If action was taken before the commercialization of GM 
products, then conflict could have been minimized. However, the lack of public 
consultation resulted in expenses and time spent on rectifying the situation.  
The commercialization of products of nanotechnology can be found in 
cosmetics, clothing and medicine is on thin ground according to Einsiedel and 
McMullen (2004). What is disturbing is that properties at the nano-scale behave 
differently and in unpredictable ways than at the macro-scale. And as Einsiedel 
and McMullen (2004) point out, few studies have been conducted to test for 
toxicity levels in regards to human health of these products. 
Mehta (2004) states that benefits from nanomedicine are possible if past 
mistakes are not repeated and if public trust can be gained. If nanotechnology 
enabled products produce hazards to human health or the environment the 
potential of nanomedicine may be jeopardized (Mehta, 2004). An incident in 
Germany had investigators scurrying to analyze whether or not a commercialized 
cleaning product called “nano magic” contained nano-particles that may have 
contributed to nearly 100 cases of respiratory problems from people who used the 
aerosol spray. (Associated Press, 2006). If these technologies are not regulated 
properly, public trust will diminish further.  
When and where is it best to introduce new policies into the existing legal 
framework? As argued by Kerr and Bassie (2004) it is not sufficient to merely 
partake in scientific forecasting. A broader network of social actors is required. It 
 
9 The Canadian government in 2004 passed legislation slating a voluntary labeling of GM 
products. Any product containing less than 5% GM product could be labeled GM free. 
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is essential that science and technology policy is developed in such a way that 
alternative futures can be assessed and accommodated (Kerr and Bassie, 2004). 
The application of “foresighting” as a methodology for thinking about a 
technology and its long-term future impacts is described by Kerr and Bassie 
(2004) as a shift from short-term to long-term thinking that incorporates a non-
linear system type approach to identify the best economic and social course. 
The use of foresighting can be applied to examine consequences; 
anticipate problems; examine implications of possible future events; and to 
identify attractive features of future societies (Kerr and Bassie, 2004). It allows 
for a wider examination of social and economic outcomes of a particular 
application of technology in society.  
Instead of standing on the side lines, cheering on a combative and 
adversarial scientific arm-wrestling match, diverse groups of social actors 
ought to assemble to examine potential profits and pitfalls of the 
technologies that miniaturized from as many different angles and 
perspectives as possible with the aim of consensus building (Kerr and 
Bassie, 2004: 59). 
 
Perhaps if foresighting and public consultation were used by Mryriad 
Genetics before commercializing their genetic tests then they could have avoided 
post-commercialization backlash. The following case study illustrates it is not 
always clear how individuals and organizations will react to the law especially if 
there was no public consultation. For instance, Williams-Jones (2002) did a case 
study of Myriad Genetics and their patenting of BRCA 1 and BRCA 2 genes. The 
genes are used as diagnostic markers for breast and ovarian cancer. This case 
study emphasized the need for social, ethical and policy-oriented examination of 
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genetic technologies. Myriad Genetics acquired the patent rights to BRCA 1 
and 2 and as such was given a monopoly position on the commercialization of 
diagnostic technology using these genes as markers. 
 To put the history of genetic patents into context, Williams-Jones (2002) 
explains that the first significant court case of Diamond  v. Chakrabarty  447 U.S 
303, on June 16, 1980 saw the overturning of prohibitions of patenting biological 
organisms10. Since then in many countries genes have been patented in so far as 
they are found to be “artificial genes” or are isolated and shown to have a 
function. By the year 2000 there were more than 25,000 DNA patents on a global 
basis (Williams-Jones, 2002). 
 In 1996 Myriad Genetics commercialized a genetic testing device that 
screened for mutated versions of BRCA 1 and BRCA 2 genes. The device was 
recalled and pulled from the marketplace after concerns of wide-spread public 
harm from lack of proper genetic counseling to prevent consumers from 
misinterpreting test results. The test was then allowed to be used only by a 
physician and when genetic counseling services could be provided.  
 In 1996 Canada used genetic testing for the BRCA 1 and BRCA2 genes 
on a research trial basis. Provincial programs were established such as the 
Hereditary Cancer Program (HCP) in British Columbia which covered genetic 
testing, patient counseling and physician and patient education on cancers with a 
genetic basis.  By October 2000 Myriad Genetics was granted Canadian patents 
on both BRCA 1 and 2 genes which was followed by a “cease and desist” letter 
 
10 Legal description of court case Diamond v. Chakrabarty 447 U.S. 303: 
http://caselaw.lp.findlaw.com/scripts/getcase.pl?navby=CASE&court=US&vol=447&page=303  
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by Myriad Genetics to all health care facilities using the genes as diagnostic 
markers. Any future testing was to be sent to MDS Laboratory Services in 
Toronto, a broker agency for Myriad Genetics in Canada.  
 The cost of a full gene analysis test was about C$3,850 (Williams-Jones, 
2002). The HCP in British Columbia stopped providing the genetic testing as they 
could not afford the fee. However, if a patient agreed to pay the fee, then HCP 
would provide genetic counseling and facilitation of the test. At the time many 
other provinces with the Hereditary Cancer Program ignored the patent rights of 
Myriad and continued to use the genes as diagnostic markers (Williams-Jones, 
2002). 
 In February 2003, the HCP of British Columbia was allowed to provide 
the testing service without a patient fee as the British Columbia Ministry of 
Health Services changed their position on honoring Myriads patent (Williams-
Jones, 2002). The national contestation against Myriad’s patent of BRCA 1 and 
BRCA 2 led to the Canadian Cancer Society and the National Institutes of Health 
to encourage the federal government to not allow Myriad’s patents to block 
testing of BRCA 1 and BRCA 2 mutations (Williams-Jones, 2002). 
 The impact of gene patents on genetic services is something that will need 
to be addressed soon as the potential for wide-range diagnostic services through 
the use of MF LOC devices becomes a reality. Depending on whether the Myriad 
patents are enforced or not will have a large influence on how scientific 
knowledge becomes integrated into the marketplace and into clinical practices 
(Williams-Jones, 2002). The examination of case studies such as this one allows 
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us to anticipate future conflicts between science and the law, and further 
amplifies the need for co-development of regulations with the production and 
knowledge and application of technology.  
 As illustrated in this section, it is integral to understand the new forms of 
knowledge production in the sciences and their potential for technological 
application in order for the construction of adequate laws to regulate the ethical 
and social implications of MF LOC devices. The role of science in risk analysis is 
to come up with new methodologies and expressions of knowledge in order that 
instruments and processes could be developed to assess risk and employ 
preventative techniques. The institutionalization of MF LOC devices will create a 
demand for regulations to protect patient privacy and confidentiality of genetic 
profiles to ensure that genetic discrimination does not occur in the workplace or 
by insurance agencies. The role of the law and the intricate relationship between 
science and technology will undoubtedly lead to much debate over the application 
of genetic and biological identification tools. It is important to also include public 
consultation in this process.  
 Although I have not discussed in detail the social construction of genetics 
and whether or not it is viable to use genetics as valid source of knowledge, I have 
alluded to the notion that the perception of what is true is just as powerful. And if 
mainstream society views genetics as an important feature in defining what it 
means to be human than the social ramifications of developing these tools needs 
to be addressed under the premise that the information garnered from MF LOC 
devices is credible. As such, I again stress that it is essential to understand the 
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perspectives of the different groups of individuals using the MF LOC devices, 
such as oncologists, and to develop laws in conjunction with the technology in a 
way that is congruent with societal ethics and values.        
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4.0 CHAPTER FOUR: METHODOLOGY 
 
In this section I provide an overview of the core processes of this research. 
First I will summarize my epistemological, theoretical and methodological 
orientations, and then I will discuss social constructionism, and include a detailed 
section of the methods involved in conducting the research. I will also briefly 
discuss reliability, validity and limitations in regards to the research. I believe, as 
does Crotty (1998), that within the research process different factors need to be 
aligned in order to have a coherent and logical understanding of your research 
investigation. There are four main elements within a research process that flow 
and feed into each other, they are: epistemology, theoretical perspective, 
methodology and methods (see Crotty, 1998).  
1. One’s epistemological perspective is related to the theory of knowledge 
that dwells within the theoretical perspective and methodology (Crotty, 1998). 
Closely related is the concept of ontology which refers to the orientation of one’s 
nature or essence of research (Mason, 2002). The ‘nature of reality’ embedded in 
my theoretical outlook for this research is stemming from a contructionist 
perspective of reality, constituting that aspects of reality can be understood 
through perceptions, discourse, attitudes, beliefs and accounts (see Mason, 2002).  
2. One’s theoretical perspective is that which underlies the methodology 
and is the philosophical reasoning which forms the methodology and beholds a 
platform for substantiating the logic and criteria embedded in the methodology 
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(Crotty, 1998). The theoretical perspective draws from the epistemological 
orientations, so in regards to my research the theoretical perspective draws from 
an orientation towards sociology of science studies and an epistemological 
perspective of social constructionism.  
3.  Methodology entails an in-depth look at the strategy, evolution, or 
design incorporated within the selection of methods used (Crotty, 1998).  The 
methodology is also influenced by one’s epistemological and theoretical 
perspectives. A qualitative approach to the social constructionist epistemology is 
used and the design of choice for this particular research is thematic analysis.  
4. Method refers to the techniques or processes by which one generated and 
analyzed data in relation to a set of research questions (Crotty, 1998). In this case 
the main method used was interviewing oncologists across Canada. A detailed 
section of the methods is discussed later in this chapter.  
These four elements build a solid foundation by which the analysis and 
results can emerge as epistemologically, theoretically and methodologically 
sound. Theoretical discourse was covered in section 4.1, the remainder of this 
section will discuss the epistemological framework of social constructionism, 
which aids to inform the methodological logic. 
  
4.1 EPISTEMOLOGICAL FRAMEWORK: SOCIAL CONSTRUCTION 
The emergence of the social analysis of science and technology studies 
initially started as a criticism of scientific determinism. And just as different 
disciplines like biology, computer science, and engineering have come together to 
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develop biotechnology, so too can different sociological methodologies and 
epistemologies converge to help better understand the ethical, social and legal 
impacts of transformative technologies. It is important to explore how we 
generate knowledge and how it affects us. According to Crotty (1998) 
constructionism posits that no there is no objective truth waiting to be discovered. 
Only through our interaction with the realities in our world can truth come into 
being. Meaning is only possible if experienced by a mind and thus is not 
discovered, but constructed. Scientific knowledge as well is developed through a 
constructed design of knowledge (see Crotty, 1998). 
Burr (1995) describes social constructionism as multi-disciplinary as it has 
been developed by several disciplines including sociology, philosophy and 
linguistics. Social constructionism takes a critical stance towards taken for 
granted knowledge and challenges notions that one can achieve knowledge 
through an unbiased, objective observation of the world (Burr, 1995). Social 
constuctionism is in stark opposition to positivism and views reality as bound 
within historical and cultural specificity. Thus knowledge is an artifact of culture 
leading to the understanding that no one way of understanding is superior to other 
ways (Burr, 1995). Burr (1995) contends that knowledge is perpetuated through 
social processes and people construct their version of knowledge through daily 
interaction; therein lays the impetus for a social contructionists’ interest in 
investigating social interactions and language.  
 The study of how we know what we know has been the bedrock of social 
studies of knowledge, and the foundation for the development of the social study 
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of science and technology. The Social Construction of Technology (SCOT) 
perspective views knowledge, including scientific knowledge, as defined as 
socially constructed and therefore is partly developed from the scientists, 
institutions (political, educational, industrial, etc), instruments and the accepted 
norms of discovery. Constructivists (Bijker, 2001) posit that the truth of scientific 
facts and development of technology should be studied as accomplishments that 
are constructed, not inherent elements of the technology. It is important that the 
social context is included when analyzing the development of science and 
technology (Bijker, 2001). 
According to Bijker (2001) the SCOT approach came forth from three 
movements including the Science and Technology Studies (STS) movement, 
Sociology of Scientific Knowledge (SSK), and the history of technology. The 
primary goals of SCOT were to study the social responsibilities of scientists, the 
risks of nuclear energy and use of nuclear weapons and environmental pollution. 
SCOT started out as a criticism against technological determinism. Technological 
determinism espoused that technology was autonomous and shaped society to a 
great deal (Bijker, 2001). Evenutally, SCOT researchers came to study both the 
impacts of technology on society and the influence of society on technology. 
Research in SCOT integrates empirical case studies with questions of the 
modernization and politicalization of society as well as the organization of 
innovation. Bijker’s (2001) heuristics of SCOT include three major steps: 
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Step one: Includes relevant social groups that view technology in the 
same way (interpretive flexibility), and provides a depiction of an artifact through 
the perspective of relevant social groups. 
Step two: The researcher analyzes how interpretive flexibility disintegrates 
due to artifacts gaining dominance over others. As different meanings are 
constructed from a technology they integrate, and finally one artifact yields from 
the process of social construction (closure, stabilization). 
Step three:  The course of stabilization is examined in an extensive 
theoretical framework: why does a social construction process follow this course 
rather than another (technological frame)? 
Bijker (2001) argues that the process of social construction is a cycle 
which begins with the development of an artifact to the technological frame to the 
relevant social group, and back to a new artifact and technological frame and so 
on. Technology also impacts social institutions so one needs to understand 
technology's impact on society. SCOT offers a conceptual framework for 
politicizing this technological culture (showing hidden political agendas, putting 
issues on the political agenda, opening issues up for political debate). Political 
decision-making can be facilitated through the cooperation of relevant social 
groups and consensus conferences, public debates, and citizen juries (Bijker, 
2001). In the application of SCOT all relevant social groups have an equal say. In 
relation to health care, concepts such as medicalization and biomedicalization are 
used by social contructionists (Conrad, 1992 and Clarke et al., 2003) to unpack 
and understand the process of medical control in society. This study will draw 
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heavily on the social constructionist orientation and in particular aspects from 
Bijker’s (2001) understanding of SCOT. Using a social constructionist 
epistemological framework, I believe, can provide a meaningful qualitative 
analysis of the current technological phenomenon under study.  
 
4.2 QUALITATIVE RESEARCH 
Quantitative research frequently draws on the use of statistical analysis to 
investigate relationships between certain variables, it is very useful, and is a more 
straightforward methodology than qualitative research. However, qualitative 
research allows for an in-depth and meaningful account of social phenomenon 
that cannot be attained through objective quantitative methods alone. The use of 
qualitative methods allows one to examine a multitude of dimensions of the social 
world including experiences of everyday life, along with the actions, perceptions 
and beliefs of the research participants and the meaning and importance of ways 
that social processes, institutions, discourses or relationships work (Mason, 2002). 
According to Mason (2002) a qualitative researcher will likely borrow 
from several reading processes to generate meaning from the data. The three most 
common include a literal, interpretive and reflexive reading. In answering the 
question ‘what constitutes as evidence in the data’ one can take a literal stance 
and evaluate the words, language and literal content within the discourse. An 
interpretive reading would essentially have the researcher construct an account of 
what one thinks the data is revealing. And the reflexive reading incorporates the 
researcher as part of the data generating process, viewing the role of interpretation 
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as coming from the researcher as going beyond the data while acknowledging 
one’s role in the generation of the data (see Mason, 2002).       
Mason (2002) advises that the systematic sorting, organizing and indexing 
can facilitate the emergence of surprises from the data that may not be as apparent 
from a less rigorous analysis. One way would be to apply cross-sectional indexing 
or categorical indexing of data which involves systematically indexing a data set 
to include different categories based on common principles (Mason, 2002). This 
will be useful in order to examine the oncologists’ responses in such a way that a 
systematic overview of the data can be achieved to ensure coverage of leading 
themes. 
Mulkay and Gilbert (1982) state that the main question queried on in 
sociology of science studies is “in view of the empirical evidence about scientists’ 
actions and beliefs, how does science actually operate?” (pg. 311). But rather the 
more useful question would be “how do scientists construct their version of what 
is going on in science rather than what is really going on in science” (pg. 314). I 
will examine the emergence of a scientific and biomedical repertoire in order to 
answer how the oncologists construct their understanding of the MF LOC device 
and the concerns around the ethical, legal and social issues of genetic testing. The 
following section will discuss the technical details of the methods used in carrying 
out the research.   
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4.3  METHODS 
The research undertaken included interviewing Canadian oncologists 
about MF LOC technology. It is important to understand how oncologists 
construct this technology. Since the initial purpose of the development of the MF 
LOC device was to diagnose and monitor patients with genetic defects and 
cancer. Interviews were conducted with Canadian oncologists during August 2004 
to February 2005. 
 A qualitative approach is used to analyze the perceptions of oncologists 
regarding the development and use of microfluidic lab-on-chip devices. I 
developed a structured 14 question instrument in consultation with Dr. Michael 
Mehta (see appendix one). A pilot study was not conducted. The questions center 
on the ethical, legal and social implications of multiple uses of MF LOC devices. 
A small sample was used in this study, and the technique for collecting informants 
means that the results of the study are not generalized to all oncologists in 
Canada. Nevertheless, studies like this are useful for highlighting the range of 
opinions on topics of social importance.  
Thirty-one oncologists were interviewed in British Columbia, Alberta, 
Saskatchewan, Manitoba, Ontario, and Nova Soctia (see appendix three). The 
time of each interview was approximately 15 minutes. Ethics approval was 
secured from the University of Saskatchewan as of June 2004. This research is 
part of a larger project under the direction of Dr. Michael Mehta at the University 
of Saskatchewan who has been funded through the Canadian Institutes of Health 
Research. The study of the oncologists’ perception is a second stage of Dr. 
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Mehta’s research investigating how MF LOC devices may impact society. The 
first stage of the research was to examine how the general public perceived this 
upcoming technology. The final stage of this project will be a series of consensus 
conferences in which various players such as oncologists, scientists, engineers, 
academics will congregate to discuss the outcome of this project.  
 The methods used to obtain a list of oncologists included conducting 
internet searches of websites listing oncologists in Canada such as 
www.cancercare.on.ca; and the snowball method of asking for referrals from the 
oncologists that were interviewed. In most cases oncologists were emailed a 
description of the research followed by a telephone call to set up an appointment. 
Microsoft Excel was used to keep track of the oncologists’ contact information 
and the appointment times. 
 To record interviews a recording device was attached to a Sasktel Vista 
350 telephone. I notified the interviewees and asked permission for the recording 
of the interview session. A preamble to the interview included a verbal consent, 
and once that was obtained I began by defining the term microfluidc lab-on-chip 
device as:  
Microfluidic platforms are microsystems that incorporate microelectronic 
and biological components onto a hand-held device. Such devices are 
currently under development, and within 5-10 years are expected to 
revolutionize how health care providers monitor human health. By placing 
the capabilities of a large diagnostic lab in a platform the size of a wrist 
watch, point-of care applications including genetic testing, 
pharmacogentic testing, and assessment of viral load may become 
commonplace in medical clinics, pharmacies, and elsewhere. To assist in 
making diagnoses, MFPs will require real-time data acquisition and 
integration with human genetic and other kinds of databases (Mehta and 
Poudrier, 2004). 
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All interviews were transcribed and prepared for textual analysis. The 
interview version that this type of research adheres to is a mixture of positivism, 
emotionalism and constructionism (Silverman, 2001). Positivism because the 
interview questions are standardized and structured such that each interviewee 
receives the exact same question with no room for the researcher to deviate from 
the question. Emotionalism because I am after the authentic perceptions and 
experiences of the oncologists in regards to their thoughts on MF LOC devices. 
Although the questionnaire is structured, the majority of the questions are open-
ended allowing for a narrative discourse to emerge from the oncologists 
interviewed.  Constructionist in that I am interested in understanding how 
oncologists create meaning.  
A literature review was conducted of the various models of knowledge 
production. This forms the backbone for understanding the importance of 
knowing who is involved in developing technology and how it may be used in 
society. A selection of various articles regarding Mode-1, Mode-2, Triple Helix 
and PNS were used to examine the differences and similarities between the 
approaches.  
Since the methodological framework selected was qualitative, I divided 
the analysis section into two different aspects. The first part is a thematic analysis 
that delves into areas of knowledge production, dependence on the professional, 
data storage, and discrimination and policy implications. The second part 
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examines how oncologists socially construct their understanding of the MF 
LOC device through the use of scientific and biomedical repertoires.  
 
4.4  RELIABILITY AND VALIDITY    
 From a reliability standpoint it is important to ensure that one’s methods 
and analysis have been thorough, careful, honest and accurate, as well that they 
appropriately address the research questions (Mason, 2002). Ensuring validity 
requires that one accurately measures or explains that which one claims to be 
measuring or explaining (Mason, 2002). In order to achieve this one must retrace 
the directions of method and the process of how one reached an interpretation.  
 For qualitative analysis the validation procedure is embedded within the 
analysis. Potter (2003) says that there is no clear distinction between validation 
and analytic procedures; the deviant cases can help to indicate whether a 
generalization is robust or insufficient. If a piece of work has coherence, meaning 
that several studies elicit similar findings than validity can be supported. Another 
way is through reader’s evaluation, since in many cases the researcher supplies 
the reader with excerpts along with their analysis this process invites the reader to 
judge for them self the significance of the claim. “Any study which cannot 
effectively show participants’ own orientations to a phenomenon, which cannot 
deal with deviant cases, which is out of line with previous research, and fails to 
offer convincing interpretations of reproduced extracts is unlikely to be worth 
serious consideration” (Potter, 2003: 19). For purposes of this study, whenever a 
discourse from a participant is referred to, the literal translation will be provided. 
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4.5 LIMITATIONS 
 Some of the limitations include the lack of ability on my side to build 
rapport with the oncologists interviewed. Since I used telephone interviews 
instead of face-to-face interviews I was not be able to use body language as a way 
to convey a strong sense of human interaction that usually allows for a more in-
depth expression of the interviewees thoughts and experiences. Although the 
research study is intended for oncologists across Canada, I was not be able to 
access the perspectives of strictly French speaking oncologists as I do not have 
French as a second language. Another impediment to the study is that many 
oncologists had not heard much about the development of MF LOC devices. I 
anticipate that this probably caused some oncologists to not want to participate in 
the interview process. Since oncologists’ time is in high demand within a 
structured health care system their ability to participate in an interview was likely 
impacted by time constraints.  
 Aside from these limitations I believe that this research will provide useful 
information about the potential risks and benefits involved with certain 
applications of MF LOC devices. An analysis of oncologists’ perceptions will 
provide insight into how an emerging technology such as MF LOC devices could 
potentially be shaped by users, and how this technology may also change the 
current practices of oncologists and other potential users. The insights gained 
from this study will contribute to the literature surrounding ethical, legal and 
social concerns of emerging transformative technologies. 
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5.0 CHAPTER FIVE: ANALYSIS AND DISCUSSION 
 
In this section I provide an analytical overview of the key themes and 
repertoires that relate to the specific thesis statements and research questions that 
were established at the onset of this research. A total of 31 oncologists were 
interviewed, twenty-four were male and seven were female. Age ranged from 31 
to 64 years, and the average age was 46.55 years. The length of years that the 
oncologists practiced at the time of the interview ranged from 1 to 33 years with 
14.74 years as an average. Oncologists were interviewed from different provinces 
in Canada including Saskatchewan, Alberta, British Columbia, Manitoba, 
Ontario, and Nova Scotia.  
Several readings of the data allowed for two separate analyses to unfold. 
The first one that will be discussed is the identification of themes that emerged 
from the responses to the questions. The second analysis involves the construction 
of repertoires that can be found within the oncologists’ discourse.  
The thematic analysis will help address the research questions regarding 
the first thesis statement of this research: understanding modes of scientific 
knowledge production will allow for a more socially and ethically responsible 
form of governance to emerge surrounding new technology applications. The 
main question pertaining to this thesis is what type of knowledge production are 
we currently experiencing? The thematic analysis will also investigate policy 
implications.  The main question surrounding this issue is what insight might 
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oncologists provide in guiding policy (laws and regulations) surrounding the 
use of MF LOC devices? 
 
5.1 THEMATIC ANALYSIS   
 
 
 
 
 
1. Thesis: Understanding the transformations of new scientific 
knowledge production will allow for a more socially and ethically 
informed mode of governance to emerge. 
 
 Question: What type of knowledge production are we currently 
experiencing? 
5.1.1  THEME: KNOWLEDGE PRODUCTION  
The main question is what type of knowledge production are we currently 
experiencing? So the impetus is on which type of knowledge production will be 
most evident in the oncologists’ responses; i.e., Mode-1, Mode-2, Triple Helix or 
Post-Normal Science? Interview question number 9 asked: what role do you think 
government, industry and universities should have in developing lab-on-chip 
technology? The responses to question 9 as well as other questions will provide a 
glimpse into the orientation that oncologists have in regards to knowledge 
production. 
Some of the oncologists commented that industry, government and 
universities are to have separate roles in the development of lab-on-chip 
technology. This is more reflective of Mode-1 specifics of knowledge production.  
9.9 Well I think the government should fund research that’s done by 
academics and I think industry should develop products that are of value 
in genetic testing. So I think that the industry has a role to play in the 
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development of the technology. So I don’t think that it should be limited 
to academics or government I think industry has an important role to play. 
 
 In participant 9’s response it is evident that according to their response, 
the production of knowledge is still done primarily in the universities and the role 
of the university is restricted to researcher. The government’s role is not one of 
co-researcher or co-developer, but simply as financier of the research. The role of 
industry takes on great significance as it is viewed as the core developer of the 
research initiative. So these clear distinct roles and separation of knowledge 
reflect the tendencies of Mode-1 ideals in that there is a separation of knowledge 
production and application. Essentially the site of knowledge production (the 
university) differs from development and application (industry) (see Gibbons et 
al., 1994).  
The majority of other responses reflected a collaborative approach ideal to 
the roles of industry, government and university in the development process. This 
supported both a Mode-2 type of knowledge production (Gibbons, 1999) and  
Etzkowitz and Leydesdorff (2000) Triple Helix thesis of knowledge production. 
Participant 10 indicated that knowledge should be achieved through collaborative 
efforts by universities and labs, and, somewhat similar to participant 9’s response, 
that government should provide financial support, but not be directly involved in 
the development of the technology. So here we see a slight shift into a Mode-2 
type of knowledge production with more emphasis on collaboration. 
 
9.10 I think that universities and labs should be working collaboratively to 
increase our knowledge and be able to develop tests that maybe useful in 
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terms of diagnosing people or giving prognostication. I think that 
government’s major role should be in funding the universities I don’t think 
that the government should be directly involved in the research itself. But 
they should have better funding access for major universities or research 
institutes to be able to give to qualified investigators. 
 
Participant 12 strongly reflects an orientation to the Triple Helix thesis by 
attributing roles to each institution while the university maintains a critical role in 
the development process in partnership with industry. Even though the public was 
not mentioned in the question as having a role in the development, participant 12 
indirectly includes the public by saying “that society in general should have input 
into how these technologies are implemented”(9.12).   
9.12 I think just like any other technological venture that involves 
something as important as a medical technology should be done in 
partnership between universities and industry. I think that given the 
societal issues and financial issues and ethical and moral issues that 
surround the development of genetic testing that the government and 
society in general should have input into how these technologies are 
implemented. 
 
Participant 2 remains vague on their perception of the role of the 
university; however, makes it clear that industry is the lead innovator by saying 
‘everyone walks hand in hand with industry’.  “Well now a days everyone walks 
hand in hand with industry I don’t think any government is developing anything 
completely alone is it?” (9.2). 
With a somewhat confusing response participant 7 claims that neither 
government, industry, nor university should take part in the development process. 
It is not made apparent through P7’s response whom the said developer would be; 
however, P7 subsequently follows up with the perspective that the university, 
government or industry should control the application of the technology. The 
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conjunction “or” is used instead of “and” thus conveying a sense of separation, 
not collaboration.  
9.7 Government, industry and university should not have any involvement 
in development of the technology because if they control the development 
of the technology we will never progress, ever. But once the technology is 
developed by the researcher, or investigator then I think the application of 
that technology should be controlled by the government or industry or by 
the universities because it is the application that would create a problem 
not the development. I think that the development should continue 
unhindered and the researchers should have their own creative avenues 
open to create the best technology possible. 
 
Another interesting comment made by P7 is that involvement by the 
government, industry and university in the development of the technology would 
not lead to progress. This lack of faith in current institutions can be read as a post-
modernist orientation; indicating that an alternative method of knowledge 
production is needed. Unfortunately, P7 does not discuss the alternative institution 
by which the “researcher or investigator” would develop the technology.    
 The inclusion of the public is characteristic of the Mode-2 model and the 
Post-Normal Science approach. Participant 4 stresses the importance of sharing 
information regarding technology with the public in order to facilitate a 
discussion. 
 
9.4 I think like any other technology you should have the public involved 
because it gives the general public a better… not control, but at least some 
understanding about how the information can be used or where it is going 
because, I would hope so anyway, that they would be more open to 
….discussion about this technology rather than it being developed in a 
closed corner some place and then being introduced quietly. 
 
 Questions concerning reliability and validity increasingly reflect the 
tendency towards a mixture of responses of who should be responsible for 
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ensuring reliability and validity. Many of the responses include reference to 
more than one institution as the overseer of confirming questions regarding 
reliability and validity.   
A person does not need be trained in the area of computer programming in 
order to use the resulting software (such as Microsoft’s PowerPoint). It is 
important to know that when one does use the program that it is reliable and valid 
software. Lab-on-chip technology, in the form of a handheld, automated device, is 
intended to enable doctors to monitor, diagnose and provide individualized care to 
patients through the analysis of single cell material, including specific genes. This 
analytical work will be possible more quickly and without the need for extensive 
laboratory space and equipment as is currently the case. The important factor that 
will impact the utility and wide-spread use of the technology is the extent to 
which it can be shown to be valid (meaning that it is measuring that which it is 
supposed to) and reliable (meaning that it will consistently give proper results). 
The oncologists interviewed were adamant throughout several questions that the 
MF LOC device would need to prove high levels of validity and reliability. Where 
the oncologists did differ in opinion was on who should be ensuring the reliability 
and validity of the product.   
 There is also an emphasis on having reliability and validity tested within a 
scientific-based institution, likely meaning a laboratory setting and having the 
information from the tests widely shared. As participant 5 indicates:  
10.5 Reliability and validity has to be done in experimental settings so I 
think whenever a test is done it has to tested in different trial format before 
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it’s put in common place like in use and it has to be published in peer 
reviewed journals. 
 
The reference to “peer reviewed journals” is reflective of Mode-1 type of 
knowledge production that emphasizes the use of experts while excluding other 
sources of potentially valid information. The emphasis on oncologists being able 
to view the data themselves is strong. The doctors do not seem willing to accept 
MF LOC devices as a diagnostic tool unless they can see through published works 
or otherwise that the technology is reliable and valid to their standards. As 
mentioned by participant 3, there is little room for accepting the diagnostic tool 
without “scientific data” to back it up. “Depending upon if I have the data I mean 
I need the scientific data so I have not reviewed the data so I cannot answer this 
question again” (13.3). 
 The type of institution that is involved in ensuring that the lab-on-chip 
technology is both valid and reliable plays an important part, and the discourse 
did not reveal any one institution as being the number one burden-of-proof  center 
for analyzing validity and reliability. A mixture of responses included the 
government, laboratories, first developers, clinicians and shared between 
government, university, and clinicians.  
10.1 I think the authorities that license the laboratories are responsible for 
that kind of a process and the laborites themselves are responsible for 
meeting certain standards. 
 
10.4 I guess the easy answer is the government. 
 
Participants 1 and 4 advocate a single institution approach to validating 
technology while the following participants 6, 7 and 10 believe that multi-
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institutional collaboration is necessary.  The tendency towards multi-
institutional collaboration supports the Triple Helix thesis of knowledge 
production. 
10.6 It should be shared responsibility. Certainly the scientific community 
meaning the researchers and clinicians should be responsible for the first 
step in terms of reliability and validity and then like there should be 
guidelines similar to the guidelines available now from organizations or 
sort of either oncology organization in general there should be some sort 
of guidelines rather than leaving things to personal preference. 
 
10.7 I think that everyone who is involved and the previous question the 
government, the industry, the university, the researchers, the users, the 
oncologists everyone has to be extremely careful in ensuring that the 
technology is reliable and it should go through a thorough testing 
procedure at the various levels before it is accepted as a common tool. 
 
10.10 Ultimately the first person who is responsible is the person 
designing the test, and so if the university is designing it, or in conjunction 
with a laboratory it is their responsibility first and foremost to ensure that 
they have done all the quality assurance mechanisms and controls that 
they require. Once the test is licensed for use that’s a federal government’s 
authority and so I think that the federal government has a responsibility 
through health Canada for oversight to review the literature that would be 
provided to them regarding it. I don’t think the government should be 
responsible for directly doing the testing but I think they have an 
obligation to ensure that the data that’s given to them is considered to be 
adequate in the scope and breadth to be able to say that the test is reliable 
and has an adequate positive and negative rate, false positive and false 
negative. 
 
 Although there is a slight dominance of orientation towards the Triple 
Helix thesis of knowledge production, there is still a mixture of Mode-1 and 2 as 
well as a slight orientation to the PNS approach. Understanding the oncologists’ 
perceptions regarding knowledge production has provided insight into which 
institutions are believed to be producing the knowledge and which should be 
responsible for ensuring validity and reliability of the products of knowledge.  
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2. Thesis:  It is important to consider who might use the technology and how it 
might impact institutional practices and individuals.  
 
Question 
1. What insight might oncologists provide in guiding policy surrounding the use 
of MF LOC devices? 
 
 
5.1.2 THEME: DEPENDENCE ON THE “EXPERT”  
Oncologists, for the most part, do not want genetic testing devices to be 
available without counsel since the average person would lack the educational 
background necessary to understand the test results, and would put themselves at 
emotional risk. The greatest concern that the oncologists had with the 
commercialization of MF LOC is that patients would resort to self-testing and 
become over-anxious of the test results. Many of the oncologists believe that a 
disconnect would occur between using the MF LOC device as a self-administered 
diagnostic tool and having adequate education (knowledge) of how to interpret 
the results.   
 
6.10 I think that the impact (on health care) would almost crush the public 
health care system in terms of patient visits because I think that patients if 
they could self test everyone would do self testing wouldn’t have any 
knowledge about what the implications would be in terms what a positive 
test would be nor would they necessarily understand false positives and 
false negatives and that would lead to a large amount of panic and a large 
amount of patient visits to their family practitioner and that will overload 
the system because it can’t cope it will also probably lead to incredible 
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amount of referrals for opinions from oncologists about how to prevent 
the cancers that might be genetically predisposed to and the cancer system 
can’t coup with volume either. I think that it would have a pretty 
devastating impact on the system overall. 
 
Participant 10 fears that commercialization and self-testing would disrupt 
the health care system and overload it with people who “wouldn’t have any 
knowledge about what the implications would be in terms of a positive test” and 
thus would result in panic.  Participant 7 is similarly concerned with panic and 
chaos and also emphasizes the need for care after the results are obtained, the role 
of the oncologist in P7’s passage is one of caretaker rather than interpreter within 
a health care system. 
 
6.7 I think that would be real chaos and anarchy because I think that if you 
are looking at a general population who may or may not have sufficient 
knowledge about various implications of various tests and so I would 
suspect that this should not become an at home pregnancy test type of 
technology because the diseases that particularly that I deal with as an 
oncologist need significant medical expertise to provide sort of care after 
the test result comes through. 
 
Participant 8 refers to the layperson as someone “who may not be able to 
interpret the results correctly” and that the laymen need “guidance of a physician 
or someone who knows how to interpret the results”. The oncologists generally 
are indicating that they do have a continual and important role in the diagnosis of 
the disease process. The idea of having that component of their job taken over by 
a “machine” essentially would likely contribute to a discourse defending the 
importance of the continual role of physician as diagnostic consultant.   
6.8  Meaning if individuals have access then anyone who could afford 
probably will want the test done although maybe that will be a benefit to I 
suppose to the company who developed it, but it may not always be a help 
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to the people who get the test done because quite often the patients or 
the laymen may not be able to interpret the results correctly and then 
secondly that particular test may not be relevant to the given person so that 
it can cause unnecessary anxiety on part of the patient. And if this are 
done then it should be done on guidance of a physician who tell at least if 
this test is relevant in your case and also the interpretation of the results 
should be done with the guidance of the physician or somebody who 
knows how to interpret the results so for the layperson like with testing for 
blood sugar results and taking insulin according to results, it is more 
complicated than that. I would be concerned if it is freely available 
because it can be misused it can be overused and it can cause unnecessary 
anxiety on part of the people who use it so it has to be done cautiously and 
I think and with help and guidance for patients. 
 
An opposite stance emerged (less frequently) within the responses that 
deviated from describing laymen as an uneducated consumer and depicted the  
“patient” as having the ability to interpret results. Although the task still remains 
contingent on education, at least a couple of the doctors interviewed believe that 
individuals are capable of self-administering and interpreting tests.  
6.9 I think it is all right as long as the patients/individuals know, are 
educated and the implications of what a positive and negative test means. 
In a way it’s not a lot different from some of the home testing that is done 
like home pregnancy testing. So I am all for being educated and if they are 
educated using the education to learn about themselves and the 
implications of that. 
 
 Particpant 9 stresses the importance of education as indicated in the above 
quote where the word “education” was used four times. When P9 was asked “how 
useful do you think lab-on-chip technology could be for individuals in remote 
locations, like Northern Canada, and developing countries?” the theme of 
education was consistent for remote areas like Northern Canada, but when the 
response focused on developing countries P9 acknowledges that there are other 
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more immediate concerns that need to be addressed before individuals would 
benefit from MF LOC technology.  
12.9 I don’t think Northern Canada is any different than anywhere else I 
think it’s um the challenge with be the education of individuals and 
making not only the technology but the education that’s required for 
patients to understand what are the implications of testing and the results. I 
think in the developing countries it is less of an issue they have other 
issues to be concerned about with nutrition and public health and safety 
and things like that so it’s less of an issue there in the developing 
countries. 
 
 It is clear, that according to the majority of the oncologists’ responses that 
having a professional who is properly informed of the procedures is necessary to 
carry out the interpretation of genetic test results in order to divert from patient 
panic and stress on the health care system.   
 
5.1.3 THEME: DISCRIMINATION AND POLICY IMPLICATIONS 
 Discrimination exists in society in many forms such as age, race, ethnicity, 
gender, socioeconomic status, etc. The application of laws is meant to limit the 
occurrence of discrimination in society, such as in the work place or obtaining 
services. Two questions in particular were meant to elicit whether or not the 
oncologists were concerned about genetic discrimination. The first question read: 
“There are currently no laws in Canada preventing companies from discriminating 
based on genetic test results. Would you be worried about discrimination if 
employers had access to results?” 
 There is a general acknowledgment from the oncologists that there are not 
sufficient laws prohibiting companies to discriminate based on genetic profiles.  
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3.7 currently there are no laws discriminating or controlling the 
companies from discriminating patients based on their health status 
whether they have a diagnosis of cancer or not or any other diagnosis for 
that matter so I don’t know whether specifically genetic test results will 
have any specific implication on that. I think it should be much more 
wider that companies should not be allowed to discriminate based on the 
health status of the individual. So, people can be prevented and I think 
employers should have a limited access to the health status which is still 
not controlled within Canada right now. 
 
 There is some ambivalence as indicated between the response of P7 and 
P16 as to currently how much legal coverage one has over their health 
information. P7 starts out by stating that “there are no laws discriminating or 
controlling the companies from discriminating patients based on their health 
status” and P16 states “there are laws to protect against…or that protect the 
privacy of your health information”. Since the question was regarding corporate 
discrimination, I assume that P16 is referring to privacy of health information 
regarding employment opportunities.     
 
3.16 I don’t think employers should be given access to the health results 
one way or another I mean it is a separate question if there isn’t laws to 
protect against those kind of things and probably that needs dealing with 
but there are laws to protect against….or that protect the privacy of your 
health information so I would hope that if things are done it’s still under 
the protection of your health information. 
 
 Some of the oncologists understood that there is that option to run genetic 
tests already; however, the big difference with the commercialization of MF LOC 
technology is that it would become more normalized and routine since the 
procedure to do genetic testing would be cheaper, quicker and easier. So although 
there are laws protecting medical files of patient health information the option to 
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subject potential employees to corporate administered testing would get around 
requiring the release of patient medical file information.   
 From an employers’ perspective the prospect of obtaining information 
regarding genetics may be viewed as another rung on the ladder for finding the 
best suited employee. Skill, intelligence, physique, and personality are currently 
popular areas of examination in job selection processes. So would not genetic 
testing simply be an additional way to “select” the best potential candidate? The 
biggest difference is that almost everyone can to some capacity improve or 
change their skills, intelligence, physique and personality these are not static. 
Genetics is more static, in that one cannot easily improve or change their genetic 
profile. Eating more broccoli may help deter the onset of some cancer but it will 
not eliminate the predisposition to cancer if one has inherited a cancer-linked 
gene. So the notion of selecting based on genetics should at least be treated in 
similar context as laws that prohibit racial discrimination. 
  
3.19 There is that possibility now with standard genetic testing. It is just 
more cumbersome right now. So I guess it’s a concern now so it’s a 
concern with any device that would make discrimination based on your 
genetics your genotype easier so that employers could purchase these 
machines and do it themselves. Where as right now patients are protected 
by rules of confidentiality about their medical data. So I think that’s where 
the concern would come from would be that employers would start testing 
patients themselves more easily and perhaps cheaply with this technology. 
 
A couple comments supported the corporate use of employee genetic 
testing. Such as from participant 17 who remarked, “Oh for sure. If I was an 
employer I would discriminate and so would the insurance companies and so 
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would even the federal government.” This comment seems rather 
inflammatory, and borderline cynical.  
 The proliferation of discrimination was also a strong concern when 
associated with insurance companies, but in comparison to the concerns expressed 
in regards to employee selection there was more acceptance among the 
oncologists when using genetic testing as a discriminatory tool for insurance 
companies. The question was asked:  “Insurance companies are always looking 
for ways to reduce risk and will increase premiums for high-risk clients. What 
role do you think lab-on-chip devices may play in setting premiums for clients? Is 
it fair for insurance companies to use these technologies?” Some participants were 
aligned with the position that it would be unfair to allow insurance companies to 
use genetic health information in order to assess client risk. As participant 6 
explains, it is not fair and it creates an unequal power balance in favor of the 
insurance companies.  
4.6 No I don’t think that it is fair. The whole idea of insurance is that you 
don’t know, but if you know then the insurance company would be the 
only benefiting partner from the relationship. The person/patient will not 
be benefiting it will be unfair to the patient. 
 
The flip side to this of course is that potential clients may go on their own 
for genetic testing and those who are given a clean slate of health (as indicative of 
their genetic profile) may be less willing to invest in health insurance. Participant 
13 sums up this sentiment quite well: “No, because the people who need the 
insurance won’t get it and people who are low risk probably don’t need to buy 
insurance” (4.13). Participant 5 is also concerned that insurance companies will 
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exploit the use of genetic testing but sees the government as having the task to 
develop appropriate regulatory protocols to limit the exploitation of genetic 
testing.  
4.5 No I don’t think the insurance companies should be given access to 
this data and the governments need to have firm regulations in place 
before this should be done. Obviously you can’t stop the technology but 
the government should have very firm rules in place otherwise I am 
positive that this is going to be exploited by insurance companies. 
 
A response reminiscent of Post-Normal Science rhetoric lays out a viable 
solution that does not single out government as the sole creator of legislation but 
also includes “patient right advocates, the company’s scientists, and physicians” 
(4.27). 
4.27 I think that there is going to need to be some careful discussions and 
legislation with a number of people including patient right advocates, the 
company’s scientists, physicians and they are going to have to come up 
with some reasonable guidelines so that people’s rights are protected and 
that they can get insurance but at the same time that business aren’t 
bankrupt somewhere there is a middle ground were those things can be 
worked out but I don’t think its an easy question to answer. I think that it 
is going to need some serious discussion and the time to do it is probably 
now because even though I don’t think these things are ready for prime 
time just yet, it is very well likely be ready in the next decade and people 
need to have thought about this complicated issue sooner rather than later. 
  
As mentioned earlier, the oncologists studied were more apt to accept the 
use of genetic testing by insurance companies than for use in employee selection. 
In some respects the acceptance emerges as the participant puts themself in the 
place of the insurance company.  “If I were in the insurance company seat I would 
say I am forced to do it there is no way I cannot do it. But as a physician I’d rather 
not have that discrimination done” (4.2). Participant 10 says it is “fair game for 
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(insurance) companies to consider employing this technology and to not agree 
to insure patients”, he/she then back-peddles by saying that they do not think it is 
ethically or morally right, but simply a case of how the insurance business is set 
up.   
 
4.10 Insurance companies are in the business of making money and so I 
think that given the way that the system is set up right now I think that it is 
fair game for companies to consider employing this technology and to not 
agree to insure patients if they find test results that this person has a high 
risk of health problems that will require cashing in on their insurance. I 
don’t necessarily think that it is ethically or morally right but you know I 
think that it is more a question on how the insurance business is set up 
than it is necessarily about what they use to determine risk. 
 
  
I surmise that the reason for this may be as a result of the hierarchal nature 
between finding a job and purchasing life insurance. Possessing a job in today’s 
society is viewed as a “need” at least in the majority of cases. Possessing life 
insurance is, I would argue, more closely related to a “desire”. In questioning the 
ethics of applying genetic testing to employee selection and insurance rate 
assessment thus requires two different sets of criteria. The purchasing of 
insurance is done out of the desire to buy security for one’s self and possibly 
one’s family. In order to purchase life insurance one needs to have money, the 
primary source of obtaining money is through employment. Thus, when genetic 
discrimination is applied in the work force then it is in the ethical domain of 
dealing with people’s livelihoods, and when genetically discriminating against 
individuals regarding insurance premiums it is in the ethical domain of dealing 
with people’s sense of security.   
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5.1.4 THEME: DATA STORAGE    
In responding to whether or not current methods of storing data are 
sufficient for protecting patient confidentiality there was no dominant response. 
Some oncologists admitted that they were not aware of how well protected the 
current methods were, “I cannot answer this question, to my knowledge it seems 
to be okay but I don’t know about it” (5.3) and “I am not aware I don’t know how 
they store (the data) but I hope they do according to like any other health care 
setting like in trials there is a coding they should probably be doing it, but I don’t 
know as I am not directly involved” (5.5).   
 Some participants felt that there are sufficient measures taken currently to 
protect patient confidentiality, however as is the case with P10, the concern lays 
with the future potential of generating greater information about the clients and 
limiting whom has access to the patient files.  
5.10 Current methods with the testing that we currently do I think they are. 
But depending on where the technological advances go and the kinds of 
information that we may get in the future that we currently don’t have 
access too because we don’t have the ability to test for, that’s when we are 
probably going to need  to have safe guards placed on to who can have 
access to that information. 
 
In some cases the onus of sufficient storage is de-focused from a 
“technical security” perspective to that of human responsibility. Essentially, the 
electronic technology available for data storage is viewed as sufficient for holding 
the data, but easily breached, as P12 indicates “I think that the technology is 
sufficient, but I don’t know that it is necessarily being implemented in a sufficient 
way.”    
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5.12 I believe that the technology that exists is sufficient but I think that 
the technology that is used to store information now that the electronic age 
its much easier to have breaches of confidentiality occur so I think that the 
technology is sufficient but I don’t know that it is necessarily being 
implemented in a sufficient way. 
 
 Participant 14 declares it is a human issue saying that “It depends on who 
is doing the storing” (5.14). Whereas participant 17 sees it as a technical issue and 
as explicated in the following quote, P17 has more confidence in the traditional 
methods of storing patient information in paper format within files.  
 
5.17 I used to think so but I am less certain of that. I don’t know how good 
the ….because it will all become stored in presumably in some kind of an 
electronic data base because that’s actually how we are all moving in 
medical records…some type of computerized stuff if it where a paper 
chart it is probably safer because it would be harder break into 30 
thousand paper charts but I think it is possible to break into 30 thousand 
computer charts. But ah so I probably think it is over 99 percent safe but I 
don’t think that it will ever be a 100 percent because we can’t even keep 
income tax results that way. 
 
The difference of shifting the storage of patient information from paper to 
electronic format is one of space containment and level of abstraction. By space 
containment I mean that the act of electronically storing data transcends a 
physical space by existing in an almost inconceivably minute amount of space. 
The information is presumably etched within a hard drive be it a local hard drive 
or a server, and can be easily copied once accessed. It also transcends physical 
institutional barriers, where once the paper files were kept physically locked 
within a file cabinet and, when the clinic is closed, physically locked within the 
building. Now the information exists in an electronic data matrix protected by 
encryption and/or codes. This transforms the storage of information from a 
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tangible artifact (paper data) to an abstract artifact (electronic data). Thus, the 
keeper of the information is becoming less physical and more abstract. As the 
threat of information access extends outside the physical barrier, the need to 
protect patient information becomes greater. The electronic storage of data can 
provide a more efficient and organized system; however, measures need to be 
taken to ensure that patient privacy and confidentiality is maintained.    
 
5.2  INTERPRETIVE REPERTOIRES  
 
 
 
Thesis 2, Question 2. How do oncologists use language to construct their 
understanding of MF LOC devices? (within the context of scientific and 
biomedical repertoire) 
 
The second part of the analysis will use interpretive repertoires to 
understand how the oncologists conceptualize and come to validate the MF LOC 
device. The main question here is how do oncologists use language to construct 
the meaning of this MF LOC device? The use of a scientific and biomedical 
repertoire emerged as the main impetus by which the oncologists grounded their 
perceptions and attitudes. 
 
5.2.1 SCIENTIFIC REPERTOIRE  
 Since I am dealing with a group of individuals who, although, come from 
different backgrounds and reside in different parts of Canada, all share the 
extensive experience of acquiring a medical degree and specializing in oncology. 
This extensive training would expose the oncologists to similar discourses and 
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ways of thinking from a scientific-medical perspective. This is quite evident in 
the use of language and reference points that rhetorically emerged through a 
scientific repertoire in many of the participants’ responses. In general the 
oncologists construct their perception of the MF LOC device based upon how it 
measures up scientifically regarding issues of validity and reliability.  
 When asked how confident would you be in trusting a lab-on-chip device 
to detect and diagnose patients, participant 20 uses the word “valid” three times 
while explaining how “trust” is generated.  
13.20 That sort of depends. It depends on how valid it was how well it was 
tested. I mean do I trust tests? I trust tests that have been well validated 
and I wouldn’t trust ones that haven’t been well validated. 
 
Participant 12 also has a similar stance and admits that at this point in time  
he/she has no confidence in the MF LOC device; however, his/her perception 
would change if the device were put through rigorous studies.  
13.12 Right now I have no confidence in it, but if it were to be 
demonstrated in rigorous studies that it worked just as well as currently 
available methods then I could certainly be convinced. I have no reason to 
think that it couldn’t happen. 
 
 There is also a sense of comparison in P12’s response which is another 
form of measurement regarding how well the new technology measures up to the 
prior technology. Statements such as “I would have to see the evidence first” 
(13.13) clearly speaks to the power of “scientific” proof. If MF LOC devices do 
fail to sufficiently pass tests of validity and reliability to the standards held by the 
potential users, then the chance for this technology to be disregarded is high. Thus 
understanding that the oncologists discourse and ultimately the way they think 
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and conceptualize phenomenon is grounded within a “scientific repertoire” can 
help clarify how they come to assess the use of MF LOC technology. 
In trying to illustrate the emergence of a “scientific repertoire” I feel that it 
is important to acknowledge that concepts such as validity, reliability and 
evidence seem intuitively appropriate for assessing the usefulness of MF LOC 
devices, but in saying this I recognize my own bias towards “scientific 
rationality”. The problem emerges when agreeing on what type of validity or 
measure of reliability is correct? Is there a “proper way” to validate the 
technology? Participant 19 says, “Things would have to be tested and validated in 
the proper way” (13.19). Participant 27 also alludes to the need to do things 
properly through a process of “standardization” and remains optimistic for future 
potential of MF LOC devices, while refraining from accepting it as currently 
reliable.   
11.27 I think it is very interesting from a research stand point. I think from 
a practical stand point working in the real world on a routine bases I think 
it has a bit of a ways to go primarily because I think that there are no 
standards about how to collect samples, how to process them, what you 
are looking at, how to analyze the results that you are looking at. So I 
think that there is a whole host of technical issues that need to be 
standardized and made more routine and reproducible from lab to lab and 
place to place before this is ready for prime time. But I think that those are 
all doable and I would suspect that there is going to be some real stuff out 
in the next five to tens years that is reliable. But my own personal opinion 
is I wouldn’t rely on it right now. 
 
The whole idea of collecting, analyzing and interpreting data is a positivist 
notion which underlies a belief in discovering truths through observation. P27 
adheres strongly to a scientific repertoire by referring to these positivist concepts. 
In ascribing to a scientific repertoire, the oncologists appear to view themselves as 
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a beholder of information, essentially an expert, and as such they take on an 
instrumental role of informing the patient of the condition of one’s body and 
informing the patient of remedial options.  
The notion of “expert opinion” is strong within the scientific repertoire. In 
some cases the oncologists view the patient as incapable of handling the 
information that the MF LOC device may provide. As participants 4 and 23 
indicate the use of MF LOC devices for self-testing would require a professional 
to interpret the results. 
6.4 I don’t think that that would be a good idea. Too much knowledge can 
be a bad thing sometimes. You know I think that it should be just like any 
other testing it should be done by a professional who is trained in the 
interpretation of these tests. You don’t necessarily want to cause people to 
become anxious or depressed about what they find out. 
 
6.23 I think if people can self test then that would create a lot of 
unnecessary anxiety. I think that any sort of testing of anything, its not just 
chip technology but you know any diagnostic test should be done in a 
setting where someone has appropriate training to interpret that results of 
those tests. So to make them really available to anybody again being a lot 
of people out there who don’t really know how to interpret the results you 
know may get things that are meaningful or may get things that aren’t 
necessarily meaningful and there is going probably, at least in the short 
term, increase the number of health care in Canada that are required to 
even to clarify that information. 
 
The justification that P4 gives is that the patient may become 
unnecessarily depressed by the results if they take it upon themselves. So, 
presumably according to P4 the oncologist would be able to present the 
information in such a manner that the patient does not become upset or depressed. 
I suppose this is possible if one takes into account that the oncologist can also 
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offer remedial options.  A comment from P1 also opposes self-testing and feels 
that the patients need “guidance”.   
6.1 I don’t think individuals should be self testing because I think they 
need a lot of guidance. I think the ramifications of acquiring information 
about yourself has to be very well understood simply because these kinds 
of tests, genetic testing, are unlike any test that most lay people are used 
to. In other words, if you have a blood sample taken from your arm and 
they give a result it says what’s going on in your body today right now. 
Whereas with genetic testing it usually gives you a prediction of what 
might happen not what will happen so it could put you at a greater risk of 
a certain disease ah but there is no guarantee that you will in fact get that 
disease and so without the proper understanding of the ramifications, for 
not only you, but your siblings and cousins and all your relatives has to be 
understood. So I think that this is very powerful technology that has to be 
managed in an appropriate way to protect people.    
 
 Participant 1 discusses the difference of a genetic test from current tests on 
the market today. Tests today give information regarding the current state of the 
body such as blood sugar levels, while genetic tests are predictive and may only 
give information predisposing the individual to a possible future condition.  The 
second last sentence in P1’s response expresses the difference, “Whereas with 
genetic testing it usually gives you a prediction of what might happen not what 
will happen so it could put you at a greater risk of a certain disease ah but there is 
no guarantee that you will in fact get that disease and so without the proper 
understanding of the ramifications, for not only you, but your siblings and cousins 
and all your relatives has to be understood”. So there is this idea that the 
information accessed by the individual not only affects their own life but since 
there is a genetic component it may also provide information about other family 
members genetic potentials. P1’s last sentence: “So I think that this is very 
powerful technology that has to be managed in an appropriate way to protect 
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people” uses the word “protect” and warns that there is potentially a danger in 
knowing about your genetic information. This perpetuates the notion that an 
expert is needed in order to help make choices about genetic testing and 
interpreting the results. It seems prudent to point out that it is just as important to 
consult groups of people outside the domain of “experts” to achieve a broader 
understanding of how genetic testing may impact society and individuals so that 
instances of stigmatization, such as in the case of the Ashkenazi Jews, can be 
avoided. 
 
5.2.2 BIOMEDICAL REPERTOIRE  
Describing an individual’s health through genetic traits is a recent 
phenomenon that not only perpetuates but also contributes to a genetic determinist 
ideology. Within the oncologists’ responses these different forms of medical 
social control become evident, especially when discussing when it is necessary for 
a patient to go for genetic counseling and be tested for genetic traits.   
The emergence of a biomedical repertoire signifies and supports the notion 
of a paradigm shift from a process of medicalization to a process of 
biomedicalization. Medicalization is defined as a process whereby non-medical 
conditions are defined and treated as a medical illness (Conrad, 1992). 
"Medicalization consists of defining a problem in medical terms using medical 
language to describe a problem, adopting a medical framework to understand a 
problem or using a medical intervention to treat it" (Conrad, 1992:211). The 
process of medicalization has transformed “deviant” behaviour and “natural life” 
 95
processes into medical conditions. Examples of deviant behaviour include: 
madness, alcoholism, homosexuality, opiate addiction, obesity, anorexia, child 
abuse, compulsive gambling, and infertility. Natural life processes include: 
sexuality, child birth, child development, PMS, menopause, aging and death" 
(Conrad, 1992:).   
In the context of medicalization, Conrad (1992) distinguished between 
different types of medical social controls: medical ideology (an elaborate medical 
model developed from social, ideological beliefs); collaboration (the collaboration 
of doctors as information providers); medical technology (drugs, surgery and 
genetic or other types of screening.) This enables instances of  “medical 
excusing” to occur from disability to the insanity defense (Conrad, 1992:216). 
Advances in genetic testing will escalate the exploitation of medical “excusing” if 
everyday individuals become labeled with certain propensities to develop 
debilitating conditions such as Huntingtons disease.   
An additional form of medical social control is medical surveillance 
(Conrad, 1992).  According to Foucault (1973 as cited in Conrad, 1992), medical 
surveillance suggests that certain conditions are analyzed through a medical gaze, 
which then allows physicians to lay claim to all symptoms and activities 
concerning the condition. Consequences of medicalization range from an 
assumption of medical moral neutrality to domination by experts and the 
indvidualization of social problems. “It decontextualizes social problems, puts 
them under medical control" (Conrad, 1992:223).  The oncologists’ responses 
exemplify much of the characteristics of a medicalization discourse; however, it 
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more strongly adheres to the processes explained through the concept of 
biomedicalization.  
Where medicalization sought to control biomedical phenomenon, 
biomedicalization sought to transform it (Clarke et al., 2003). Biomedicalization 
is the incorporation of molecular biology, biotechnologies, genomization, 
transplant medicine and new medical technologies which - in conjunction with 
computers and information technology - to institutionally transform medical 
practices (Clarke et al., 2003).  
The technoscientific innovations in biomedicine have inaugurated an era 
of biomedicalization. Biomedicalization is an intensive extension of 
medicalization. "Biomedicalization is our term for the increasingly complex, 
multisited, multidirectional processes of medicalization that today are being 
extended and reconstituted through the emergent social forms and practices of a 
highly and increasingly technoscientific biomedicine" (Clarke et al., 2003:162). 
Clarke et al. (2003) described the current surge of advanced biomedical 
technologies as a transformation from the phenomenon of medicalization to 
biomedicalization.  
The shift to biomedicalization occured around 1985, although there is no 
single occurrence or phenomenon that pre-empted the shift. Increasingly 
technoscientific innovations culminated to bring about revolutions in biomedicine 
(Clarke et al., 2003). The commodification of health, and a focus on individual 
responsibility for health care is a focus of biomedicalization. The 
conceptualization of health risks and continual self monitoring has led to an  
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environment of the  “worried well”, "rendering us ready subjects for health 
related discourses, commodities, services, procedures and technologies (Clarke et 
al., 2003:163). This leaves little room for individuals to not be “at risk”. 
Key elements in biomedicalization include clinical innovations such as 
new diagnostic tools (such as microfluidic lab-on-chip devicies), treatments from 
genomics, proteomics (study of proteins), and genetic engineering. The 
biomedicalization era recognizes not only disease and illness as its medical 
jurisdiction but also the health of the individual (Clarke et al., 2003). Another core 
premise of biomedicalization is that science, technology and social change are co-
produced within biomedicine.  
Advances in computer technology and data banking are also embedded in 
the backbone of biomedicalization. The application of computer technologies 
within multiple biomedical domains and their organizational infrastructure are 
thereby mutually constructed, creating new social forms for orchestrating and 
performing the full range of biomedical related work (Clarke et al, 2003). The 
convergence of information technology, molecular biology and the mapping of 
the human genome make way an increasing incidence of biomedicalization in 
technoscientific cultures. The development of the MF LOC device is yet another 
avenue in which the process of biomedicalization is taking place.  
In analyzing the responses from the oncologists it is clear that the 
introduction of MF LOC devices into clinical practices and society at large will 
contribute to the commoditization of health and a larger emphasis on individual 
action for health care. Clarke et al. (2003) argue that individuals are evaluated 
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based on varying degrees of risk as either low, moderate or high. Each level is 
defined by certain reduction protocols the individual is expected to buy into and 
take responsibility for themselves. Health becomes less medicalized as the onus of 
responsibility falls less on the physician and more on the individual. Participant 
29 discuses the empowerment of the individual  “giving patients power, people 
power and control over their own health is a modern development in medicine 
and there is a concerted effort on part of the medical community to try to 
empower patients and this is quite a substantial patient empowerment tool”.  
6.29 The other aspect of that is if patients have access to this technology a 
lot of patients would be testing themselves and I’m sure there would be 
some results that were positive, true positives, that would be a significant 
benefit. But I would imagine there would be a lot of both false negatives 
as well as false positives and that might drive up consultation and 
excessive investigations and that might also have a significant impact on 
healthcare. But that being said you know giving patients power, people 
power and control over their own health is a modern development in 
medicine and there is a concerted effort on part of the medical community 
to try to empower patients and this is quite a substantial patient 
empowerment tool. We would have to very carefully consider that and 
consider what the costs would be and the implications would be in terms 
of our medical system versus patient interest.  
 
Participant 24 expresses that it is “up to the patient” as to whether they 
should be tested for diseases if no treatments are available.  
7.24 That’s up to the patient. If they want to know if they have got a 
hereditary disease it is up to the patient. Ya I think it is up to them, if they 
want it they should be allowed to have it. 
  
A common justification for the testing of genetic diseases is that it helps with 
making life decisions regarding family planning. This increases the emphasis of 
individual responsibility for health care not only for one’s self but for the future 
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potential of offspring. Participant 12 illustrates this by saying it is valuable for 
“people who have genetic pre-dispositions to serious illnesses in their family for 
the purposes of family planning.” Other participants also expresses this sentiment 
such as  P13. There  is a sense that an individual’s behaviour would be affected 
not only in family planning, but also in their own lives…a sort of do-it-before-
you-die sentiment as expressed in the following phrase by P13:  “doing things 
before it is too late”.   
7.12 I think sometimes there is a need to do that. I think that there is a 
argument to be made that such tests can be of value in for people who 
have genetic pre-dispositions to serious illnesses in their family for the 
purposes of family planning for example or for the purpose of planning 
their own lives you know if someone is going to die at the age of fifty of 
Huntington’s disease then they may wish to know that ahead of time even 
if there is no affective treatment. So Yes. 
 
 
7.13 I guess in some situations ya like Huntington’s you want to know to 
make where it is distinctly hereditary to make decisions about having 
children and maybe life decisions of doing things before it is too late. So 
ya I guess a qualified yes. 
 
 Having knowledge about an individual’s genetic make-up can also lead to 
stigmatization. This stigmatization is not only relegated to society at large but also 
within one’s own family as illustrated in the point that Participant 2 raises: 
3.2 I think that is something that we have to start thinking about now and 
see that it doesn’t happen. Not only employers it might be if a father has 
two children one of whom has a genetic abnormality and the other does 
not will they start thinking I should spend more money on education and 
the life of the normal kid. It’s not only the company it is the whole social 
status will that change it in the home in the school in the playground. 
Those things have to be thought of. 
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The commoditization and individualization of genetic testing receives a lot of 
power and prestige from the potential, not only to help diagnose a patient, but to 
predict a future potential of developing a disease. As participant 1 indicates 
“which will probably be able to predict whether people will respond to treatment 
or not and give us some idea of prognosis” there is also a potential to predict if an 
individual will respond well to certain treatments.  
12.1 Well I think it will apply to anybody in any place who needs 
treatment ah so I think if you take a look at the DNA arrays that are being 
developed through this micro-chip technology which will probably be able 
to predict whether people will respond to treatment or not and give us 
some idea of prognosis that will probably prevent a lot of resistance to 
various systemic agents on which we use for treating cancer or it might 
even allow us to do interventions early on in life of people, no matter 
where they live, so that they create lifestyles that are probably going to 
diminish their chance of  getting type-two diabetes or some other 
genetically related disease. 
 
Participant 1 also hits on the concept of commoditization through the 
process of buying into preventative treatments if a disease potential is detected 
before it has developed, and says that early interventions would allow the 
individual to “create lifestyles that are probably going to diminish their chance of 
getting type-two diabetes or some other genetically related disease.” Essentially, 
as genetic testing becomes more “normalized” it will lead to transformations at 
the institutional and individual level.  
Participant 26 argues that as testing becomes more prevalent even for non-
treatable genetic diseases, the epidemiological benefits may paint a picture of how 
much more common a disease is then was once believed. This in itself may 
provide enough support to invest further research to search for a cure:    
 101
 
7.26 That’s a difficult one. Testing for disease when there is no treatment 
for it has some benefits in the long run because it gives you an idea from 
an epidemiological point of view as to the extent of the disease, how wide 
spread it is and of course what is not available today may be available 
tomorrow and if one finds that a disease is much more common than one 
thinks that will act as an impetus to find a cure in the long run so it has 
some benefits but it is sort of a clouded benefit. 
 
The idea of tracking a disease and controlling symptoms through 
technological devices is quite characteristic of biomedicalization. Participant 29 
notes that testing early would allow one to be “able to track the progress of 
disease and be able to intervene when symptoms are controllable by the 
technologies and from what we have at the time.” 
7.29 Yes I do. You need an explanation of why? I think information is 
important to have even though a treatment at that point in time is not 
available it doesn’t mean that it wouldn’t become available in the near 
future and being able to track the progress of disease and be able to 
intervene when symptoms are controllable by the technologies and from 
what we have at the time. So yes even if we can’t effectively treat the 
disease we might be able to treat symptoms and at least give the patients 
an explanation of why certain things would be happening to them. So yes I 
do think it is important to test for things even if we don’t have treatment 
for them. 
 
There is a some concern within the responses that the oncologists do not 
believe that it will be possible for a machine to ultimately diagnose a patient since 
a multitude of factors converge to help with the diagnostic process and no 
machine will be able to give an all encompassing diagnosis. This is exemplified in 
participants’ 7 and 10 response:  
13.7 The device would probably give you sufficient indication as to what 
is wrong but it may not necessarily give you a diagnosis of a disease 
complex. Specific information for example the level of hemoglobin or the 
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level of blood urea or all that information might be quite precise or 
might be reliable but to diagnose a patient which is a whole syndrome of 
complicated combination of things I’m not too sure whether the device 
would do that.  
 
13.10 I wouldn’t be confident at all in having it being the full method of 
diagnosing. I would be comfortable if the technology were sophisticated 
enough with appropriate testing for it to serve as a complimentary test to 
traditional methods of diagnosis, but if it is to be considered to be the only 
thing I would not accept a patient referral solely on the basis of lab-on 
chip technology. 
 
 
 This indicates that there still exists a significant role on the part of the 
oncologists to fully diagnose and treat patients. The general acceptance of the MF 
LOC device is that of a “complimentary” tool to aid with the “traditional methods 
of diagnosis” (P10). However, the question remains: to what degree will a genetic 
testing tool contribute to the process of labeling individuals as “genetically 
abnormal”?  The coding of the human genome has also allowed scientists to 
biomedicalize DNA by translating it into meaningful bits of information and 
according to Kay (1999: 224), the “human genome is now generally viewed as an 
information system, as a book of life written in DNA language or DNA code to be 
read and edited. Genetic make-up is increasingly becoming the benchmark of 
health and wellness. Hall (2003) argues that the “gene” is more or so embedded in 
a socially constructed form of body and health.  "The new genetic knowledge is 
embedded within and extends the biomedical interpretation of health and the 
body, and continues the narrowing penetration of the medical gaze into the body" 
(Hall, 2003;151).  It was mind boggling how many times the oncologists used the 
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word “abnormal” when discussing genetics; participants 23, 24 and 5 
exemplify this.    
11.23  I guess I am answering from probably the point of view of chip 
technology I think that people are embracing sort of genetic testing in 
areas such as you know I guess from a cancer point of view then you 
know with some of the known abnormalities particularly breast cancer 
because that’s probably the area where it is most developed. 
 
8.24 So the if the patient wants it we will do it if we think that there is, if I 
think that it is going to change management then I will send the patient for 
example with BRCA where there is an increased risk of ovarian cancer 
and I want to see if other members of the family have the abnormality then 
I will do that because it will influence prognosis if I know that they are at 
risk of getting breast or ovarian cancer then I would want to know that. 
 
2.5 Well it has started being used for a lot of DNA micro tests looking at 
genetic abnormalities and specifically for oncological diseases and 
hematological diseases to identify the mutations are translocations or 
abnormalities where we are kind of initiating our focus of those diseases 
and met those with those conditions and I guess that that will be very 
helpful in deciding what are the changes causing these ….how they relate 
to other diseases and whether there are any particular patterns so I think 
that it will be very helpful. 
 
The extensive use of the term “abnormal” signifies an association with a 
scientific deterministic philosophy.  Engaging in genetic determinism ignores the 
environmental and social context in which a subject is situated. "This dominant 
'genocentric' discourse is producing an embedded knowledge of direct and 
deterministic relationship between genes and an ever widening spectrum of 
physiological and psychological conditions" (Lippman, 1999 as cited in Hall, 
2003:151). Another metaphor that is found within the genetics discourse is that of 
a “gene map”. The concept of a gene map is used to help scientists make sense of 
their actions in decoding the human genome. "The gene map is the central 
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analytical tool of the new genetic knowledge. It operates both as an 
information tool in the gathering of data and as a framework for the subsequent 
interpretation of genetic information and the linking to conditions of health and 
illness" (Hall, 2003:152). 
Haraway uses the term “reification” to describe gene mapping as an 
avenue to change an abstract idea into a concept that then leads to the process of 
materialization (Haraway, 1997, as cited in Hall, 2003:158). Hall (2003) warns 
that biomedicalization of medical practices and reconceptualizing the body within 
the framework of “genetic health” and the use of diagnostic devices has major 
costs for the future. Consequences such as over-stressing the health care system if 
many patients are tested positive for so called “defective” genetic traits.  As 
indicated in the oncologists’ discourse the health care costs would be 
surmountable especially if individuals had access to MF LOC device as a public 
commodity.  
6.10 I think that the impact (on healthcare) would almost crush the public 
health care system in terms of patient visits because I think that patients if 
they could self test everyone would do self testing wouldn’t have any 
knowledge about what the implications would be in terms what a positive 
test would be nor would they necessarily understand false positives and 
false negatives and that would lead to a large amount of panic and a large 
amount of patient visits to their family practitioner and that will overload 
the system because it can’t coup it will also probably lead to incredible 
amount of referrals for opinions from oncologists about how to prevent the 
cancers that might be genetically pre disposed to and the cancer system 
can’t coup with volume either. I think that it would have a pretty 
devastating impact on the system overall. 
 
 There were a couple responses from the oncologists that recognized the 
limitation of technology and the output of results. As with participant 23 they did 
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not reject the technology as legitimate; however, they acknowledge that it is 
“not a precise science”. 
3.23 Oh I think so because I think it is hard to know what all the results of 
a lot of the information. I mean with the technology that is there you have 
the ability to look a genetic testing and its not a precise science. I mean if 
you have a genetic abnormality then that is clear but I mean you can have 
risk, you may well carry unknown genetic abnormalities based on family 
history you can be a carrier. So I don’t think that genetic testing 
necessarily provides you know all of the answers and again I think that 
discrimination based on those answers is probably not appropriate. 
 
Although the evidence overwhelmingly leans towards a biomedical 
repertoire this does not mean that the majority of oncologists were in favor of 
using or introducing the MF LOC device into their practice or society at large. In 
fact as we will see in the next few quotes the dystopian oriented repertoires were 
just as strong as the utopian repertoires.  
Of those who held a dystopian view of MF LOC technology a reigning 
theme of skepticism filtered through the responses. “It would benefit if it works. I 
am obviously skeptical that there is anything out there right now that is even close 
to being feasible” (14.11). Aligning the technology to science fiction or fantasy 
occurred through several responses such as with participant 11: 
9.11 I think that the university has a big role in it because it is still what I 
call a science fantasy it is still the figment of somebody’s imagination with 
very few exceptions. 
 
Participant 20 was not impressed by the concept of a MF LOC device and 
blatantly expressed his view: 
2.20 That sounded like a load of crap to me a very exaggerated claims, 
very complex journalized load of shit to me. It didn’t sound like it was 
grounded in the particular realities of a specific technological 
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development. You have to remember that in terms of application in 
cancer medicine at the moment I think the way we practice on average in 
cancer medicine today lags at least twenty years behind state of the art. 
Those are the realities in terms of diagnostics in the way things are 
practiced and also in therapeutics. I am a therapeutic radiologist and if you 
look at my access to pet scanning which is a low technology, I have none 
and if you look at my ability to apply modern conformal radial therapy I 
have none. That it is a technology that is ten years old the first one a 
technology that has been widely available for twenty. So the medicine that 
we practice today is a best the medicine of 1990. (2.20) 
 
 
 Participant 20 was quite defensive and felt that the explanation of MF 
LOC technology was “very exaggerated claims”. His response is emotionally 
charged and does not readily accept the belief that MF LOC devices will used in 
clinical practices in the near future. P20 emphasized a twenty year gap between 
research development and application for cancer medicine.    
Some of the oncologists who held a utopian view of the potential of MF 
LOC technology were extremely excited as well as cautious. Participants 25 and 
26 are nothing short of exuberant about the MF LOC technology.  
 
12.25 Wonderful. Absolutely marvelous so long as they don’t break down 
often. I am sure that if they are doing that then they can be linked to 
wireless and can project results and all these other good things at a 
distance so that people that who might know what was happening could 
interpret them and make meaningful interventions so I think that would be 
the gift of it all even if you were just doing CBC’s and liver functions 
studies you know really easy stuff. 
 
1.26 Oh definitely we see it everyday you know there are so many 
different advances we benefit from now that didn’t exist even fifteen years 
ago and it certainly has led to improvements in health care not only in 
quality but also being able to manage larger quantity of patients in a 
shorter period of time. 
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 In many cases as illustrated with participant 25’s response the 
oncologist supported the MF LOC technology, but also made it clear that they are 
aware of the potential of technology failure, as P25 says, “Absolutely marvelous 
so long as they don’t break down often.” Participant 26’s response represents the 
utopian view and credits technology as bettering health care, “there are so many 
advances we benefit from now that didn’t exist even fifteen year s ago”. Many of 
the utopian responses were also contingent on time as the oncologists 
acknowledged that MF LOC devices may not contribute immediately but rather 
some time in the future. Participant 31 sums it up nicely by saying “In 2005 not at 
all, but in 2015 hopefully” (12.31).  
 Regardless of the timing, the majority of oncologists acknowledged the 
potential for MF LOC devices to impact and transform medical practices. The 
support of a biomedical repertoire indicates that the introduction of MF LOC 
devices will bring with it transformations of medical practices and possibly 
transformations in other facets of life too. 
 
 
 
 
 
 
 
 
 108
 
 
 
6.0 CHAPTER SIX: CONCLUSION 
 
In this concluding chapter I will revisit the various modes of knowledge 
production and recap the findings from the analysis of themes and repertoires. 
The purpose of this study was to illustrate the need for a more socially and 
ethically informed governance of transformative technology. To successfully 
achieve such an institution this thesis argued that it is important to understand 
where and how knowledge is produced. I also provided an example, by way of 
interviewing oncologists, to illustrate how various experts/actors can be consulted 
in order to understand from a broader perspective the potential benefits and 
concerns that introducing a new technology may have on institutions and 
individuals.  
The thesis that understanding the current forms of scientific knowledge 
production will allow for a more socially and ethically responsible form of 
governance to emerge is substantiated through the thematic analysis of the 
oncologists’ responses regarding knowledge production. The question that 
followed from this thesis was what type of knowledge production are we currently 
experiencing?  I will return now to a brief review of the different models 
regarding knowledge production.  
The characteristics of Mode-2 model of knowledge production as 
explained by Nowotny, Scott and Gibbons (2001) refers to an open system of 
knowledge production. This open system requires a new social contract between 
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society and science. This contract includes a co-evolution of science and 
society that is contingent upon a dialectical relationship whereby open 
communications and influence are intermittent between science and society. 
 Society’s impact on science thus leads to a more socially robust form of 
knowledge production. The public no longer participates solely through 
representative institutions, but engages and participates more directly by voicing 
concerns, joining debates, and making consumer conscious decisions.  
 There is a shift from “reliable knowledge” to “socially robust” knowledge. 
The fundamental aspects of “reliable” knowledge are intact; however, what has 
changed is the scope by which knowledge becomes validated. It no longer solely 
rests on the consensus of “peer groups”, but must also pass the inspection of a 
range of experts and actors. The “socially robust” regime includes the entire 
scientific community along with the public to participate in the discourse. 
Scientists are thus encouraged to go out into the “agora” and converse with the 
public primarily through media avenues on issues regarding scientific knowledge. 
The public can then “speak back”, thus providing an opportunity to renegotiate 
the scientific endeavors. Science is also no longer a fixed process as the experts 
are increasingly required to discuss non-scientific issues to a diverse audience.  
The role of the university under the description of Mode-2 thesis has also 
decreased and has been replaced by other institutions that produce knowledge. 
This is where Etzkowitz and Leydesdorff’s  (2000) model of the Triple Helix 
largely differs from Mode-2 model of knowledge production. The Triple Helix 
model highlights the links between university, academia and industry as ever 
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increasing, largely in part due to advances in information technology. The 
university’s role in innovation is not diminishing, but rather enhancing and 
evolving. The government’s role has increased which substantiates the evolution 
of a knowledge production through a trilateral network. The potential economic 
impact is what drives the movement of scientific knowledge production. So how 
much a scientific endeavor impacts the economy will determine the amount of 
resources and attention a project is warranted. The Triple Helix thesis maintains 
that so long as the university sustains the essential mandate to “educate” it secures 
its role in the knowledge production process. According to the Triple Helix thesis 
the relations between the university, industry and government are all vital for 
supporting the success of a knowledge based society.  
 As a way to manage the risks associated with developments in scientific 
knowledge Ravetz (2004) contends that the employment of PNS principles is 
important. The PNS approach is similar to Mode-2 characteristics in that there is 
an increased emphasis on public participation and inclusion of an extended expert 
domain to contribute to the decision-making process regarding the development 
and application of new technologies. What Ravetz (2004) adds is the application 
of the precautionary principle in times of uncertainty and when the stakes are 
high. The participation of public and extended expert communities can be met 
through focus groups, citizen juries, consensus conferences or stakeholder forums. 
Ideally, the development of an independent institution to facilitate these processes 
would help.  
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 No model captures the holistic nature of the current processes by 
which knowledge is produced. As evident through the oncologists’ responses it 
would seem that the Triple Helix thesis is most supported. However, remnants 
from the Mode-2 and Mode-1 models also emerged. There was little evidence of 
the PNS orientation; however, the PNS approach has more to do with an idyllic 
way to manage risks brought on through developments from scientific knowledge. 
Post-Normal Science ideology is a call for what should be, rather than a 
description of what is. Essentially, an amalgamated model of the current 
perspectives of knowledge production is still best suited.  
 In building capacity to devise an institution or committee to oversee 
certain ethical, legal or social implications of emerging technologies it is essential 
to understand and to seek input of various actors and experts involved in the 
knowledge production process. The remainder of this conclusion will focus on the 
second objective of this thesis which was to illuminate the importance of 
considering who might use the technology and how it might impact institutional 
practices and certain groups of people. This exemplifies one way of encouraging 
the scientists and other experts to discuss non-scientific issues. The first question 
was what insight might oncologists provide in guiding policy surrounding the use 
of MF LOC devices?   
 Many of the oncologists cautioned that the commercialization of MF LOC 
devices for self-testing would lead to devastating consequences on part of the 
individual and on the health care system. The diagnosis process involves more 
than finding a genetic link. According to several oncologists, the patients are 
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diagnosed based on multiple factors including symptomatic behavior. The 
health care system is at risk of becoming bombarded by anxious individuals who 
will want to know what their self-administered test results mean even if they are 
symptom free, thus leading towards Clark et al.’s (2003) concept of the “worried 
well”.  
 The opportunity for a new type of genetic discrimination to emerge in 
society has some oncologists feeling uneasy. The interesting finding that emerged 
out of the oncologists’ discourse on discrimination was that even when discussing 
genetic discrimination in the work force the general response from the oncologist 
was that it is not fair to include genetic information in the employee selection 
process, and laws need to be in place to prevent genetic discrimination. However, 
when it came to the use of genetic information regarding insurance premiums 
there was a significant increase in the amount of responses that did not outright 
oppose discriminating based on genetic profiles.  
 I speculated that the reason for the difference in attitude regarding genetic 
discrimination between employment selection and insurance premiums lies in the 
value distribution between livelihood and sense of security. Applying genetic 
discrimination against one’s livelihood is far more detrimental than applying it 
against one’s sense of security. A livelihood represents a “need”, purchasing 
health insurance is a “desire”.  
 In determining whether or not current methods of storing patients’ health 
information were sufficient the doctors’ responses were mixed. A key message 
was that the electronic storage of data was sufficient, but it is not being 
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implemented properly. Meaning that the opportunity for accessing patient 
information and breeching confidentiality is still perceived as high. The electronic 
storage of data transcends physical barriers and thus outside threats from expert 
computer hackers become a reality. Ensuring that the best possible software is 
installed to prevent systems hackers is an obvious answer, as well as limiting the 
number of people who know codes that enable access to patient files.  
 Insights that the oncologists provide regarding individual and institutional 
impacts of commercialization, heightened potential for genetic discrimination and 
the need for more secure data storage systems can help to inform policy and 
decision makers of the potential transformations that MF LOC devices will have 
on society, thus contributing to a more ethical, legal and socially informed 
governance of MF LOC devices.  
 The second question to the second thesis statement attempted to unlock 
the use of language and repertoires to understand how the use of  scientific and 
biomedical repertoires serve to shape the oncologists’ perceptions and concerns 
regarding acceptance and application of MF LOC devices. Knowing that the 
oncologists work within a perspective of scientific and biomedical repertoires has 
provided insight into how oncologists fashion their beliefs and thus how they 
came to construct their understanding and concerns regarding MF LOC 
technology.  
As indicated earlier, the educational experiences of studying and working 
within the area of medical oncology gives rise to a shared scientific repertoire. 
The oncologists make sense and base their acceptance of MF LOC technology on 
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measures of validity and reliability. These two concepts adhere to positivist 
notions and are characteristic of a scientific ideology. Trust is accomplished 
through evidence of validity and reliability. The concept of time and comparison 
of performance emerge as critical factors within the scientific repertoire. Many of 
the oncologists are skeptical of the technology today, but believe they would 
change their mind in years to come as “time” would allow for sufficient measures 
of reliability and validity. The comparison component stresses the importance of 
demonstrating similar or improved techniques from the traditional forms of 
testing. The requirement of “scientific proof” is vital and thus the oncologists’ 
assessment of the usefulness of the MF LOC technology is grounded within a 
scientific repertoire.  
 Another common element that supports the use of a scientific repertoire 
was the underlying notion that the oncologists perceived themselves as an 
“expert” and therefore the beholder of knowledge. Not only does the oncologist 
possess the knowledge to interpret the test results, but they also can better manage 
the patients’ distress when dealing with the information by providing the patient 
with information to help prevent or lessen the symptoms of the disease. Providing 
this information will likely decrease the patients’ feelings of hopelessness. 
Providing the patient with something to do to help control the disease can lead to 
patient empowerment.        
 The oncologists’ discourse also reflects a biomedical repertoire in that 
there is an increasing awareness of the convergence of technology and 
information systems that work to transform the practices in medical institutions 
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and the experiences of the patient. The shift from medicalization to 
biomedicalization is truly a shift from control to transformation (Clarke et al., 
2003). Biomedicalization is an integration of natural science and computer 
technology with the purpose to transform medical practices (Clarke et al., 2003). 
The development and application of MF LOC technology is a good illustrations of 
what the concept of biomedicalization seeks to understand.  
 The evidence of a biomedical repertoire within the oncologists’ responses 
is congruent with the characteristics of the biomedicalization paradigm. Many 
oncologists emphasized the importance of seeking professional help when 
choosing to carry out genetic testing. Although most oncologists do not agree 
with commercializing MF LOC devices for self-testing, they do recognize the 
shift of responsibility onto the patient to take control of their own health. As 
genetic testing becomes the norm the prevalence of commoditizing health will 
also increase and more people will be directed to take control of their health by 
employing preventative therapies. Information garnered through genetic testing 
not only affects the actions that an individual may take on their own health, but 
also may impact decisions regarding family planning. The notions of tracking and 
controlling diseases also supported the emergence of a biomedical repertoire. As 
some oncologists made reference to the importance of testing for incurable 
diseases so that epidemiological studies could flourish with the hope of finding a 
cure.  
 There is not a full submission of relegating the MF LOC device into the 
biomedicalization paradigm. The oncologists maintain that the MF LOC device is 
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a “complimentary” tool meant to help with “traditional methods of diagnosis”. 
In comparing the utopian and dystopian repertoires it is evident that the MF LOC 
device will not be readily accepted by all; but the majority does contend that the 
potential is there for the device to significantly enhance and transform practices at 
the institutional and individual level.  
Understanding where and how knowledge is produced will help inform the 
decision makers of whom to consult with in order to facilitate a broader 
understanding of the ethical, legal and social implications of introducing a new 
technology. Future research in this area should include an account of the 
perceptions of other groups of people who may be affected by MF LOC 
technology. It would be ideal to assess the perceptions and concerns of other 
groups of people whom do not construct their meanings through a scientific or 
biomedical repertoire.   
 The quest to continually enhance our existence through technological 
advances will not stop. It is imperative that insightful guidance co-develops to 
shape transformative technology trajectories. Not unlike Beasely, the fire-creating 
early hominid, we need to continually assess our situation and strategically align 
best practices in order to minimize harm and promote benefit. The development 
of smaller, quicker and cheaper genetic testing devices will undoubtedly affect 
our current conceptualizations of humanity and health. Further understanding of 
the social impacts is needed to better guide the introduction of MF LOC devices 
into society.  
 
 117
 
REFERENCES  
Alpert, S.A. 2003. Protecting medical privacy: challenges in the age of genetic 
    information. Journal of Social Issues 59, 2: 301-322. 
 
Associated Press. April 13, 2006. German nano-scare prompts FDA probe. 
    Foxnews.com. Retrieved April, 2006 from: 
    http://www.foxnews.com/story/0,2933,191657,00.html 
 
Backhouse, C.J., Footz, T., Adamia, S., and Pilarski, L.M. 2003. Microfluidic   
    chips for molecular analysis of human cancer. Proceedings, International   
    Conference on  Mems, Nano, and Smart Systems, ed. Badawy, W. and Moussa,  
    W. 377-387. 
 
Beck, U. 1999. World Risk Society.  Malden, Ma.: Polity Press. 
 
Bijker, W. E. 2001. Social construction of technology. International Encyclopedia 
     of the Social and Behavioural Sciences, 15522-15527 
 
Braaten, J. 1991. Habermas’s critical theory of society. State University of  
    Albany: New York Press. 
 
Burr, V. 1995. An Introduction to Social Constructionism. London: Routledge.  
 
Clarke, A.E.; Shim, J.K.; Mamo, L.; Fosket, J.R. and Fishman, J.R. 2003. 
    Biomedicalization: technoscientific transformation of health, illness, and U.S.  
    biomedicince. American Sociological Review 68, 2: 161-189. 
 
Collins, H.M. 2002. Sociology of scientific knowledge. International 
    Encyclopedia of the Social and Behavioural Sciences.  
 
Conrad, P. 1992. Medicalization and social control. Annual Review of Sociology 
    18: 209-232. 
 
Crotty, M. 1998. The Foundation of Social Research: Meaning and Perspective in   
     the Research Process. London: Sage Publication. 
 
De Marchi, B. D. and Ravetz, J. R. 1999. Risk management and governance. 
    Futures 31, 7: 743-757. 
 
Einsiedel, E.F. and McMullen, G. 2004. Stakeholders and technology: challenges 
    for nanotechnology. Health Law Review 12, 3: 5-9. 
 
 118
Etzkowitz, H. and Leydesdorff, L. 2000. The dynamics of innovation: from  
    national systems and ‘mode 2’ to a triple helix of university-industry- 
    government relations. Research Policy 29: 109-123.  
 
Everett, M. 2003. The social life of genes: privacy, property and the new 
    genetics. Social Science and Medicine 56, 53-65. 
 
Encyclopedia Britannica. Definition of technology: retrieved December, 2005 
    from: http://www.britannica.com/eb/article?tocId=9380375 
 
ETC Group. January 2003 report. The big down: atomtech-technologies 
    converging at the nano-scale.  
 
Foucault, M. 1975. The Birth of the Clinic: An Archeology of Medical   
    Perception. New York: Vintage Books. 
 
Gibbons, M. 1999. Science’s new social contract with society. Nature 402: C81- 
    C82. 
 
Gibbons, M., Limoges, C., Nowotny, H., Schwartzman, S., Scott, P., and Trow, 
    M. 1994. The New Production of Knowledge: The Dynamics of Science and 
    Research in Contemporary Societies.  Thousand Oaks, California: Sage  
    Publications. 
 
Gilbert, N.G. and Mulkay, M. 1982. Warranting scientific belief. Social Studies of  
    Science. 12, 3: 383-408. 
 
Goffman, E. (1963). Stigma: notes on the management of spoiled identity. 
    Englewood Cliffs, NJ: Prentice-Hall. 
Hall, E. 2003. Reading maps of the genes: interpreting the spatiality of genetic 
    Knowledge. Health and Place 9, 2: 151-161.  
Jasanoff, S. 2001. Science and law. International Encyclopedia of the Social and 
    Behavioural Sciences, 13614-13621. 
 
Kay, L. 1999. In the beginning was the word: the genetic code and the book of  
    life. In The Science Studies Reader, ed. M. Biagioli, 224-233. New York and 
    London: Routledge.   
 
Kerr, I. and Bassie G. 2004. Building a broader nano-network. Health Law 
    Review 12, 3: 57-62. 
 
Kezar, A. and Eckel, P.D. 2004. Meeting today’s governance challenges: a 
    synthesis of the literature and examination of a future agenda for scholarship. 
 119
    The Journal of Higher Education 75, 4: 371-399.  
  
Kuhn, T. 1970. The structure of scientific revolutions. Chicago: University of  
    Chicago Press. 
 
Leiss, W. 2001. The Chamber of Risks: Understanding Risk Controversies.  
    Montreal, Qc.: McGill-Queen’s University Press. 
 
Levidow, 2001. Precautionary uncertainty: regulating gm crops in europe. 
    Social Studies of Science 31, 6: 842-874.  
 
Leydesdorff, L. and Etzkowitz, H. 2001. The transformation of university- 
    industry-government relations. Electronic Journal of Sociology 5, 4. 
 
Lujan, J.L. and Moreno, L. 1996. Biological lottery and social solidarity: The  
    impacts of genetic diagnosis. Futures  28, 5: 497-500. 
 
Mason, J. 2002.Qualitative researching, 2nd edition. London: Sage Publication. 
 
Mehta, M.D. 2004. The future of nanomedicine looks promising, but only if we 
    learn from the past. Health Law Review, 13, 1: 16-18.  
 
Mehta, M.D. and Poudrier, J.D. 2004. Microfluidic platforms, genetic databases,  
    and biosociality. In Blood and data: ethical, legal and social aspects of  
    human genetic databases, ed. G. Arnason, S. Nordal and V. Arnason, 17-22.  
    University of Iceland Press.  
 
Mehta, M.D. 2005. Biotechnology Unglued: Science, Society, and Social 
    Cohesion. Vancouver: UBC Press.     
 
Mulkay, M. and Gilbert, N.G. 1982. What is the ultimate question? some remarks 
    in the defense of the analysis of scientific discourse. Social Studies of 
    Science12, 2: 309-319.  
 
Nicolescu B. 2002. Manifesto of transdisciplinarity. Translated from French by 
    Karen-Claire Voss. New York: State University of NewYork Press. 
 
Nowotny, H., Scott, P., and Gibbons, M. 2001. Re-Thinking Science: Knowledge  
    and the Public in an Age of Uncertainty. Malden, MA.: Polity Press. 
 
Pilarski, L., Mehta, M., Caufiled, T., Kaler, K., Backhouse, C. 2004.  
    Microsystems and nanoscience for biomedical applications: a view to the 
    future. Bulletin of  Science, Technology and Society 24, 1: 40-45. 
 
Potter, J. 2003. Discourse analysis and discursive psychology in P.M. Camic, 
 120
    J.E. Rhodes and Li Yardley (Eds). Qualitative research in Psychology:    
    Expanding perspectives in methodology and design (pp. 73-94).  Washington: 
    American Psychological Association.  
 
Ravetz, J. and Funtowicz, S. 1999. Post-normal science – an insight now 
    maturing. Futures 31: 641-646. 
 
Ravetz, J. 2003. A paradoxical future for safety in the global knowledge  
    economy.  Futures 35, 8: 811-826. 
 
Ravetz, J. 2004. The post-normal science of precaution. Futures 36, 4: 347-357. 
 
Rosenau, P.M. 1992. Post-modernism and the social sciences: insights, inroads,  
    and intrusion. Princeton, New Jersey: Princeton University Press. 
 
Shinn, T. 2002. The Triple Helix and new production of knowledge: prepackaged 
    thinking on science and technology. Social Studies of Science 32 4: 599-614. 
 
Silverman, D. 2001. Interpreting qualitative data: Methods for analyzing talk, text 
    and interaction. 2nd Ed. Sage Publications. 
 
Staeder, T. 2002. How microfluidics works. Technology Review 105, 8: 77.  
Stratford Beacon-Herald. 2003. Ag Canada in bed with Monsanto. December 11,  
    2003. Retrieved December 28, 2005 from:  
    http://www.non-gm-farmers.com/news_details.asp?ID=915 
 
Tognetti, S.S. 1999. Science in a double bind: gregory bateson and the origins of 
    post-normal science. Futures 31: 689-703. 
 
Williams-Jones, B. 2002. History of a gene patent: tracing the developments and 
    application of commercial BRCA testing. Health Law Journal 10: 123. 
 
World Nuclear Association, description of Chernobyl accident, retrieved  
    January 2006 at:  http://world-nuclear.org/info/chernobyl/inf07.htm. 
 
 
 
 
 
 
 
 
 
 
 121
 
 
APPENDIX ONE: QUESTIONNARE 
 
1. In general, do you believe that technological advances contribute positively to 
health care? 
 
2. What impacts do you see lab-on-chip technology having on oncologists, lab 
technicians, and patients? 
 
3. There are currently no laws in Canada preventing companies from 
discriminating based on genetic test results. Would you be worried about 
discrimination if employers had access to results? 
 
4. Insurance companies are always looking for ways to reduce risk and will 
increase premiums for high-risk clients. What role do you think lab-on-chip 
devices may play in setting premiums for clients? Is it fair for insurance 
companies to use these technologies? 
 
5. Do you believe current methods of storing data are sufficient for protecting 
patient confidentiality?  
 
6. What do you think would be the impact on health care if lab-on-chip devices 
were commercialized and individuals had access to self testing for cancers and 
other diseases? 
 
7. Do you think diseases should be tested for when there are no effective 
treatments available? 
 
8. Under what circumstances do you advise your patients to seek genetic 
counseling? 
 
9. What role do you think government, industry and universities should have in 
developing lab-on-chip technology? 
 
10. Who should be responsible for ensuring reliability and validity of this 
technology? 
 
11. In your view, how fully do you think the research community has embraced 
this technology? 
 
12. How useful do you think lab-on-chip technology could be for individuals in 
remote locations, like Northern Canada, and developing countries? 
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13. How confident would you be in trusting a lab-on-chip device to detect and 
diagnose patients? 
 
14. Would this technology benefit or hinder your practice as an oncologist? 
 
Profile 
The interview is now complete. Finally, I would like to ask a few questions for 
demographic purposes. 
 
Gender (ask only if necessary):       Male______   Female_______ 
 
What is your age in years_____. If unwilling to provide, how about the 
following range? 
 
• 26-35 
• 36-45 
• 46-55 
• 56-65 
• 66-75 
• 76+ 
 
About how long have you been practicing as an oncologist in years?_____If 
unwilling to provide, how about the following range? 
 
• 1-5 
• 6-10 
• 11-19 
• 20 or more 
 
What Province do you live in? 
 
Closing 
Thank-you for taking the time to participate in this interview. We appreciate your 
time and value your opinions. If you are interested in following our project, please 
do so by accessing our website at: www.music.net.ca. If you have any questions 
or concerns, please contact the lead researcher, Dr. Michael Mehta, of the 
University of Saskatchewan at (306) 966-6917, or the Office of Research Services 
at the University of Saskatchewan at (306) 966-8576. 
 
Thank-you 
Good-bye. 
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APPENDIX TWO: INTERVIEW CONSENT FORM 
 
I am inviting you to take part in a research project, being led by Dr. Michael 
Mehta, of the University of Saskatchewan.  The proposed research has been 
approved on ethical grounds by the University of Saskatchewan Behavioral 
Research and Ethics Board.   
 
This project is entitled Novel Platforms for Genetic Analysis.  This particular 
project is part of a larger project with scientific and medical researchers at the 
University of Alberta and University of Calgary. The overall objective of this 
project is to “assess how Canadians understand issues related to health 
information, genetic testing, and privacy” and to assess how medical practitioners 
(oncologists) in Canada perceive the use of microfluidic platform technologies for 
clinical applications. 
 
You are being asked to participate in the interview portion of the study.  The 
interview will last approximately fifteen minutes. The interview recordings will 
be transcribed word for word, and the recordings and transcripts will be securely 
stored by Dr. Mehta at the University of Saskatchewan (in a locked filing cabinet 
in Room 1015 Arts) for a minimum of five years following the end of the study 
period. You may choose to withdraw your participation at any time, and your 
withdrawal will not reflect unfavourably upon you in any way.   
 
Should you agree to participate, your responses will be kept confidential. Names 
and other identifying information will be removed from all publicly released data, 
and your identity will not be disclosed unless otherwise requested. If any direct 
quotations are used from your transcript, they will be attributed to a pseudonym. 
Results from this study may be published in academic journals and may be 
presented at various conferences. 
 
If you have any questions or concerns regarding the study, you may discuss these 
with the researcher or contact Dr. Michael Mehta of the Department of Sociology 
at the University of Saskatchewan at 306-966-6917. Questions regarding your 
rights as a participant may be directed to the Office of Research Services at 306-
966-2084. 
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APPENDIX THREE: DESCRIPTION OF ONCOLOGISTS CITED 
 
Particpant no. Sex Age Years in practice Province
1 M 64 33 Saskatchwan
2 F 41 7 Saskatchwan
3 M 31 1 Saskatchwan
4 M 38 4 Saskatchwan
5 M 40 5 Saskatchwan
6 M 49 20 Saskatchwan
7 M 53 16 Saskatchwan
8 M 59 22 Saskatchwan
9 M 56 25 Saskatchwan
10 M 35 5 Alberta
11 M 56-65 27 Alberta
12 M 33 2 Alberta
13 M 44 11 Alberta
14 F 46-55 15 Alberta
16 F 36 7 Alberta
17 M 57 29 Alberta
19 M 43 10 Ontario
20 M 56 25 Ontario
23 M 39 10 Ontario
24 M 53 21 Manitoba
26 M 60-65 26 British Columbia
29 M 32 3 Ontario
31 F 37 8 Nova Scotia  
 
 
 
 
  
 
 
 
 
 
 
 
 
